{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:59:13Z","timestamp":1792184353523,"version":"4.4.0"},"reference-count":325,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03323-3","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T21:30:20Z","timestamp":1755120620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comorbidity of hypertension and lung cancer: interplay of genetics and environment"],"prefix":"10.1007","volume":"16","author":[{"given":"Jingtong","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Difang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"3323_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global disparities of hypertension prevalence and control: A systematic analysis of Population-Based studies from 90 countries. Circulation. 2016;134:441\u201350.","journal-title":"Circulation"},{"key":"3323_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/HYPERTENSIONAHA.120.16044","volume":"77","author":"S Kidoguchi","year":"2021","unstructured":"Kidoguchi S, Sugano N, Tokudome G, Yokoo T, Yano Y, Hatake K, Nishiyama A. New concept of Onco-Hypertension and future perspectives. Hypertension. 2021;77:16\u201327.","journal-title":"Hypertension"},{"key":"3323_CR3","doi-asserted-by":"publisher","first-page":"110813","DOI":"10.1016\/j.envres.2021.110813","volume":"195","author":"F Chen","year":"2021","unstructured":"Chen F, Fu W, Shi O, Li D, Jiang Q, Wang T, Zhou X, Lu Z, Cao S. Impact of exposure to noise on the risk of hypertension: A systematic review and meta-analysis of cohort studies. Environ Res. 2021;195:110813.","journal-title":"Environ Res"},{"key":"3323_CR4","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3323_CR5","doi-asserted-by":"publisher","first-page":"e5414","DOI":"10.1136\/bmj.e5414","volume":"345","author":"F Barone-Adesi","year":"2012","unstructured":"Barone-Adesi F, Chapman RS, Silverman DT, He X, Hu W, Vermeulen R, Ning B, Fraumeni JF Jr., Rothman N, Lan Q. Risk of lung cancer associated with domestic use of coal in xuanwei, china: retrospective cohort study. BMJ. 2012;345:e5414.","journal-title":"BMJ"},{"key":"3323_CR6","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1001\/jamaoncol.2023.2144","volume":"9","author":"D Zhang","year":"2023","unstructured":"Zhang D, Xi Y, Boffa DJ, Liu Y, Nogueira LM. Association of wildfire exposure while recovering from lung cancer surgery with overall survival. JAMA Oncol. 2023;9:1214\u201320.","journal-title":"JAMA Oncol"},{"key":"3323_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/01.HYP.0000227932.13687.60","volume":"48","author":"ME Dickson","year":"2006","unstructured":"Dickson ME, Sigmund CD. Genetic basis of hypertension: revisiting angiotensinogen. Hypertension. 2006;48:14\u201320.","journal-title":"Hypertension"},{"key":"3323_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00001573-199609000-00002","volume":"11","author":"NK Hollenberg","year":"1996","unstructured":"Hollenberg NK. Genes, hypertension, and intermediate phenotypes. Curr Opin Cardiol. 1996;11:457\u201363.","journal-title":"Curr Opin Cardiol"},{"key":"3323_CR9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11906-001-0068-9","volume":"3","author":"NK Hollenberg","year":"2001","unstructured":"Hollenberg NK. A genome-wide search for susceptibility loci to human essential hypertension. Curr Hypertens Rep. 2001;3:7\u20138.","journal-title":"Curr Hypertens Rep"},{"key":"3323_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1375\/twin.8.5.499","volume":"8","author":"JJ Hottenga","year":"2005","unstructured":"Hottenga JJ, Boomsma DI, Kupper N, Posthuma D, Snieder H, Willemsen G, de Geus EJ. Heritability and stability of resting blood pressure. Twin Res Hum Genet. 2005;8:499\u2013508.","journal-title":"Twin Res Hum Genet"},{"key":"3323_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00041552-199703000-00015","volume":"6","author":"GH Williams","year":"1997","unstructured":"Williams GH, Fisher ND. Genetic approach to diagnostic and therapeutic decisions in human hypertension. Curr Opin Nephrol Hypertens. 1997;6:199\u2013204.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3323_CR12","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1152\/physrev.00035.2016","volume":"97","author":"S Padmanabhan","year":"2017","unstructured":"Padmanabhan S, Joe B. Towards precision medicine for hypertension: A review of genomic, epigenomic, and microbiomic effects on blood pressure in experimental rat models and humans. Physiol Rev. 2017;97:1469\u2013528.","journal-title":"Physiol Rev"},{"key":"3323_CR13","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","volume":"50","author":"E Evangelou","year":"2018","unstructured":"Evangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H, Ntritsos G, Dimou N, Cabrera CP, Karaman I, et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet. 2018;50:1412\u201325.","journal-title":"Nat Genet"},{"key":"3323_CR14","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/ng.3667","volume":"48","author":"GB Ehret","year":"2016","unstructured":"Ehret GB, Ferreira T, Chasman DI, Jackson AU, Schmidt EM, Johnson T, Thorleifsson G, Luan J, Donnelly LA, Kanoni S, et al. The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat Genet. 2016;48:1171\u201384.","journal-title":"Nat Genet"},{"key":"3323_CR15","doi-asserted-by":"publisher","first-page":"2461845","DOI":"10.1155\/2018\/2461845","volume":"2018","author":"D Li","year":"2018","unstructured":"Li D, Sun Y, Kong X, Luan C, Yu Y, Chen F, Chen P. Association between a single nucleotide polymorphism in the 3\u2019-UTR of ARHGEF18 and the risk of nonidiopathic pulmonary arterial hypertension in Chinese population. Dis Markers. 2018;2018:2461845.","journal-title":"Dis Markers"},{"key":"3323_CR16","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jtho.2018.03.024","volume":"13","author":"SR Carr","year":"2018","unstructured":"Carr SR, Akerley W, Cannon-Albright LA. Genetic contribution to nonsquamous, Non-Small cell lung cancer in nonsmokers. J Thorac Oncol. 2018;13:938\u201345.","journal-title":"J Thorac Oncol"},{"key":"3323_CR17","doi-asserted-by":"publisher","first-page":"7948","DOI":"10.18632\/aging.102301","volume":"11","author":"D Liu","year":"2019","unstructured":"Liu D, Ma Z, Yang J, Zhao M, Ao H, Zheng X, Wen Q, Yang Y, You J, Qiao S, Yuan J. Prevalence and prognosis significance of cardiovascular disease in cancer patients: a population-based study. Aging. 2019;11:7948\u201360.","journal-title":"Aging"},{"key":"3323_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1200\/JCO.2012.44.1170","volume":"31","author":"CD Williams","year":"2013","unstructured":"Williams CD, Stechuchak KM, Zullig LL, Provenzale D, Kelley MJ. Influence of comorbidity on Racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer. J Clin Oncol. 2013;31:475\u201381.","journal-title":"J Clin Oncol"},{"key":"3323_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/CAD.0000000000001133","volume":"33","author":"W Xiu","year":"2022","unstructured":"Xiu W, Huang Y, Li Y, Yu M, Gong Y. Comorbidities and mortality risk among extensive-stage small-cell lung cancer patients in Mainland china: impacts of hypertension, type 2 diabetes mellitus, and chronic hepatitis B virus infection. Anticancer Drugs. 2022;33:80\u201390.","journal-title":"Anticancer Drugs"},{"key":"3323_CR20","doi-asserted-by":"crossref","unstructured":"Dima S, Chen KH, Wang KJ, Wang KM, Teng NC. Effect of Comorbidity on Lung Cancer Diagnosis Timing and Mortality: A Nationwide Population-Based Cohort Study in Taiwan. Biomed Res Int 2018, 2018:1252897.","DOI":"10.1155\/2018\/1252897"},{"key":"3323_CR21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/aje\/kwg179","volume":"158","author":"A Lindgren","year":"2003","unstructured":"Lindgren A, Pukkala E, Nissinen A, Tuomilehto J. Blood pressure, smoking, and the incidence of lung cancer in hypertensive men in North karelia, Finland. Am J Epidemiol. 2003;158:442\u20137.","journal-title":"Am J Epidemiol"},{"key":"3323_CR22","doi-asserted-by":"publisher","first-page":"44877","DOI":"10.1038\/srep44877","volume":"7","author":"H Han","year":"2017","unstructured":"Han H, Guo W, Shi W, Yu Y, Zhang Y, Ye X, He J. Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci Rep. 2017;7:44877.","journal-title":"Sci Rep"},{"key":"3323_CR23","doi-asserted-by":"publisher","first-page":"24884","DOI":"10.1038\/s41598-024-76896-8","volume":"14","author":"A Drab","year":"2024","unstructured":"Drab A, Kanadys W, Malm M, Wdowiak K, Dolar-Szczasny J, Barczy\u0144ski B. Association of endometrial cancer risk with hypertension- an updated meta-analysis of observational studies. Sci Rep. 2024;14:24884.","journal-title":"Sci Rep"},{"key":"3323_CR24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41569-024-01017-x","volume":"21","author":"NS Wilcox","year":"2024","unstructured":"Wilcox NS, Amit U, Reibel JB, Berlin E, Howell K, Ky B. Cardiovascular disease and cancer: shared risk factors and mechanisms. Nat Rev Cardiol. 2024;21:617\u201331.","journal-title":"Nat Rev Cardiol"},{"key":"3323_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/ehjqcco\/qcad036","volume":"10","author":"H Nagasawa","year":"2024","unstructured":"Nagasawa H, Kaneko H, Suzuki Y, Okada A, Fujiu K, Takeda N, Morita H, Nishiyama A, Yano Y, Node K, et al. Association of cancer with the risk of developing hypertension. Eur Heart J Qual Care Clin Outcomes. 2024;10:228\u201334.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"3323_CR26","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1161\/01.HYP.37.5.1251","volume":"37","author":"A Lindgren","year":"2001","unstructured":"Lindgren A, Pukkala E, Nissinen A, Kataja V, Notkola IL, Tuomilehto J. Cancer incidence in hypertensive patients in North karelia, Finland. Hypertension. 2001;37:1251\u20135.","journal-title":"Hypertension"},{"key":"3323_CR27","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/CIRCRESAHA.121.318051","volume":"128","author":"DCH van Dorst","year":"2021","unstructured":"van Dorst DCH, Dobbin SJH, Neves KB, Herrmann J, Herrmann SM, Versmissen J, Mathijssen RHJ, Danser AHJ, Lang NN. Hypertension and prohypertensive antineoplastic therapies in cancer patients. Circ Res. 2021;128:1040\u201361.","journal-title":"Circ Res"},{"key":"3323_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/HJH.0000000000000770","volume":"34","author":"JL Harding","year":"2016","unstructured":"Harding JL, Sooriyakumaran M, Anstey KJ, Adams R, Balkau B, Brennan-Olsen S, Briffa T, Davis TM, Davis WA, Dobson A, et al. Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and new Zealand cohorts. J Hypertens. 2016;34:149\u201355.","journal-title":"J Hypertens"},{"key":"3323_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.critrevonc.2014.08.004","volume":"93","author":"S Abi Aad","year":"2015","unstructured":"Abi Aad S, Pierce M, Barmaimon G, Farhat FS, Benjo A, Mouhayar E. Hypertension induced by chemotherapeutic and immunosuppresive agents: a new challenge. Crit Rev Oncol Hematol. 2015;93:28\u201335.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3323_CR30","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/HJH.0000000000002006","volume":"37","author":"V Katsi","year":"2019","unstructured":"Katsi V, Magkas N, Georgiopoulos G, Athanasiadi E, Virdis A, Masi S, Kliridis P, Hatziyanni A, Tsioufis C, Tousoulis D. Arterial hypertension in patients under antineoplastic therapy: a systematic review. J Hypertens. 2019;37:884\u2013901.","journal-title":"J Hypertens"},{"key":"3323_CR31","unstructured":"Silvestry FE, St John Sutton MG. Sustained-release calcium channel antagonists in cardiovascular disease: Pharmacology and current therapeutic use. Eur Heart J 1998, 19 Suppl I:I8\u201314."},{"key":"3323_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.amjmed.2003.08.027","volume":"116","author":"MJ Eisenberg","year":"2004","unstructured":"Eisenberg MJ, Brox A, Bestawros AN. Calcium channel blockers: an update. Am J Med. 2004;116:35\u201343.","journal-title":"Am J Med"},{"key":"3323_CR33","doi-asserted-by":"publisher","first-page":"902305","DOI":"10.3389\/fphar.2022.902305","volume":"13","author":"B Fu","year":"2022","unstructured":"Fu B, Dou X, Zou M, Lu H, Wang K, Liu Q, Liu Y, Wang W, Jin M, Kong D. Anticancer effects of amlodipine alone or in combination with gefitinib in Non-Small cell lung cancer. Front Pharmacol. 2022;13:902305.","journal-title":"Front Pharmacol"},{"key":"3323_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.7326\/M17-3203","volume":"168","author":"RM Carey","year":"2018","unstructured":"Carey RM, Whelton PK. Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American college of cardiology\/american heart association hypertension guideline. Ann Intern Med. 2018;168:351\u20138.","journal-title":"Ann Intern Med"},{"key":"3323_CR35","first-page":"e282","volume":"134","author":"CW Yancy","year":"2016","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr., Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, et al. 2016 ACC\/AHA\/HFSA focused update on new Pharmacological therapy for heart failure: an update of the 2013 ACCF\/AHA guideline for the management of heart failure: A report of the American college of cardiology\/american heart association task force on clinical practice guidelines and the heart failure society of America. Circulation. 2016;134:e282\u2013293.","journal-title":"Circulation"},{"key":"3323_CR36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","volume":"362","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S. Effects of Candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362:759\u201366.","journal-title":"Lancet"},{"key":"3323_CR37","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","volume":"11","author":"I Sipahi","year":"2010","unstructured":"Sipahi I, Debanne SM, Rowland DY, Simon DI, Fang JC. Angiotensin-receptor Blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol. 2010;11:627\u201336.","journal-title":"Lancet Oncol"},{"key":"3323_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bcp.2018.04.012","volume":"154","author":"S Ishikane","year":"2018","unstructured":"Ishikane S, Hosoda H, Nojiri T, Tokudome T, Mizutani T, Miura K, Akitake Y, Kimura T, Imamichi Y, Kawabe S, et al. Angiotensin II promotes pulmonary metastasis of melanoma through the activation of adhesion molecules in vascular endothelial cells. Biochem Pharmacol. 2018;154:136\u201347.","journal-title":"Biochem Pharmacol"},{"key":"3323_CR39","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1086\/423857","volume":"75","author":"JE Bailey-Wilson","year":"2004","unstructured":"Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Wiest JS, Fain P, Schwartz AG, You M, Franklin W, et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet. 2004;75:460\u201374.","journal-title":"Am J Hum Genet"},{"key":"3323_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.lungcan.2020.08.012","volume":"148","author":"L Ang","year":"2020","unstructured":"Ang L, Chan CPY, Yau WP, Seow WJ. Association between family history of lung cancer and lung cancer risk: a systematic review and meta-analysis. Lung Cancer. 2020;148:129\u201337.","journal-title":"Lung Cancer"},{"key":"3323_CR41","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.jtho.2023.06.018","volume":"18","author":"CL Wang","year":"2023","unstructured":"Wang CL, Hsu KH, Chang YH, Ho CC, Chiang CJ, Chen KC, Cheung YC, Huang PC, Chen YR, Chen CY, et al. Low-Dose computed tomography screening in relatives with a family history of lung cancer. J Thorac Oncol. 2023;18:1492\u2013503.","journal-title":"J Thorac Oncol"},{"key":"3323_CR42","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.ejca.2012.01.038","volume":"48","author":"ML Cot\u00e9","year":"2012","unstructured":"Cot\u00e9 ML, Liu M, Bonassi S, Neri M, Schwartz AG, Christiani DC, Spitz MR, Muscat JE, Rennert G, Aben KK, et al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the international lung cancer consortium. Eur J Cancer. 2012;48:1957\u201368.","journal-title":"Eur J Cancer"},{"key":"3323_CR43","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.amjhyper.2005.09.025","volume":"19","author":"IB Goldstein","year":"2006","unstructured":"Goldstein IB, Shapiro D, Guthrie D. Ambulatory blood pressure and family history of hypertension in healthy men and women. Am J Hypertens. 2006;19:486\u201391.","journal-title":"Am J Hypertens"},{"key":"3323_CR44","doi-asserted-by":"crossref","unstructured":"Valerio L, Peters RJ, Zwinderman AH, Pinto-Sietsma SJ. Association of family history with cardiovascular disease in hypertensive individuals in a multiethnic population. J Am Heart Assoc 2016, 5.","DOI":"10.1161\/JAHA.116.004260"},{"key":"3323_CR45","doi-asserted-by":"publisher","first-page":"793","DOI":"10.7150\/ijms.33967","volume":"16","author":"C Li","year":"2019","unstructured":"Li C, Sun D, Liu J, Li M, Zhang B, Liu Y, Wang Z, Wen S, Zhou J. A prediction model of essential hypertension based on genetic and environmental risk factors in Northern Han Chinese. Int J Med Sci. 2019;16:793\u20139.","journal-title":"Int J Med Sci"},{"key":"3323_CR46","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/ng.109","volume":"40","author":"CI Amos","year":"2008","unstructured":"Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, et al. Genome-wide association scan of Tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008;40:616\u201322.","journal-title":"Nat Genet"},{"key":"3323_CR47","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1097\/JTO.0b013e3181b244ef","volume":"4","author":"AG Schwartz","year":"2009","unstructured":"Schwartz AG, Cote ML, Wenzlaff AS, Land S, Amos CI. Racial differences in the association between SNPs on 15q25.1, smoking behavior, and risk of non-small cell lung cancer. J Thorac Oncol. 2009;4:1195\u2013201.","journal-title":"J Thorac Oncol"},{"key":"3323_CR48","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","volume":"73","author":"T Gutschner","year":"2013","unstructured":"Gutschner T, H\u00e4mmerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73:1180\u20139.","journal-title":"Cancer Res"},{"key":"3323_CR49","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-017-0674-z","volume":"16","author":"J Jen","year":"2017","unstructured":"Jen J, Tang YA, Lu YH, Lin CC, Lai WW, Wang YC. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression. Mol Cancer. 2017;16:104.","journal-title":"Mol Cancer"},{"key":"3323_CR50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1089\/gtmb.2019.0193","volume":"24","author":"X Mou","year":"2020","unstructured":"Mou X, Wang J, Wang L, Wang S. Correlation between single nucleotide polymorphisms of the rs664589 locus in the Long-Chain noncoding RNA lung adenocarcinoma Metastasis-Associated gene 1, hypertension, and its mechanism. Genet Test Mol Biomarkers. 2020;24:120\u201330.","journal-title":"Genet Test Mol Biomarkers"},{"key":"3323_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/cncr.22795","volume":"110","author":"Y Minegishi","year":"2007","unstructured":"Minegishi Y, Tsukino H, Muto M, Goto K, Gemma A, Tsugane S, Kudoh S, Nishiwaki Y, Esumi H. Susceptibility to lung cancer and genetic polymorphisms in the alcohol metabolite-related enzymes alcohol dehydrogenase 3, aldehyde dehydrogenase 2, and cytochrome P450 2E1 in the Japanese population. Cancer. 2007;110:353\u201362.","journal-title":"Cancer"},{"key":"3323_CR52","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.4103\/0366-6999.183413","volume":"129","author":"XX Ma","year":"2016","unstructured":"Ma XX, Zheng SZ, Shu Y, Wang Y, Chen XP. Association between carotid Intima-media thickness and aldehyde dehydrogenase 2 Glu504Lys polymorphism in Chinese Han with essential hypertension. Chin Med J (Engl). 2016;129:1413\u20138.","journal-title":"Chin Med J (Engl)"},{"key":"3323_CR53","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/hr.2009.3","volume":"32","author":"M Tsuchihashi-Makaya","year":"2009","unstructured":"Tsuchihashi-Makaya M, Serizawa M, Yanai K, Katsuya T, Takeuchi F, Fujioka A, Yamori Y, Ogihara T, Kato N. Gene-environmental interaction regarding alcohol-metabolizing enzymes in the Japanese general population. Hypertens Res. 2009;32:207\u201313.","journal-title":"Hypertens Res"},{"key":"3323_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12199-015-0490-2","volume":"21","author":"M Ota","year":"2016","unstructured":"Ota M, Hisada A, Lu X, Nakashita C, Masuda S, Katoh T. Associations between aldehyde dehydrogenase 2 (ALDH2) genetic polymorphisms, drinking status, and hypertension risk in Japanese adult male workers: a case-control study. Environ Health Prev Med. 2016;21:1\u20138.","journal-title":"Environ Health Prev Med"},{"key":"3323_CR55","doi-asserted-by":"crossref","unstructured":"Mangum KD, Li Q, Hartmann K, Bauer TM, Wolf SJ, Shadiow J, Moon JY, Barrett E, Joshi A, de Saldana G et al. Epigenetic alteration of smooth muscle cells regulates endothelin-dependent blood pressure and hypertensive arterial remodeling. J Clin Invest 2025.","DOI":"10.1101\/2024.07.09.24310178"},{"key":"3323_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41588-018-0303-9","volume":"51","author":"A Giri","year":"2019","unstructured":"Giri A, Hellwege JN, Keaton JM, Park J, Qiu C, Warren HR, Torstenson ES, Kovesdy CP, Sun YV, Wilson OD, et al. Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. Nat Genet. 2019;51:51\u201362.","journal-title":"Nat Genet"},{"key":"3323_CR57","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.apsb.2020.09.009","volume":"11","author":"NF Meor Azlan","year":"2021","unstructured":"Meor Azlan NF, Koeners MP, Zhang J. Regulatory control of the Na-Cl co-transporter NCC and its therapeutic potential for hypertension. Acta Pharm Sin B. 2021;11:1117\u201328.","journal-title":"Acta Pharm Sin B"},{"key":"3323_CR58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41389-021-00307-0","volume":"10","author":"SH Lee","year":"2021","unstructured":"Lee SH, Kim O, Kim HJ, Hwangbo C, Lee JH. Epigenetic regulation of TGF-beta-induced EMT by JMJD3\/KDM6B histone H3K27 demethylase. Oncogenesis. 2021;10:17.","journal-title":"Oncogenesis"},{"key":"3323_CR59","doi-asserted-by":"crossref","unstructured":"Sanchez A, Houfaf Khoufaf FZ, Idrissou M, Penault-Llorca F, Bignon YJ, Guy L, Bernard-Gallon D. The functions of the demethylase JMJD3 in cancer. Int J Mol Sci 2021, 22.","DOI":"10.3390\/ijms22020968"},{"key":"3323_CR60","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/1541-7786.MCR-20-0948","volume":"19","author":"J Yang","year":"2021","unstructured":"Yang J, Wang X, Huang B, Liu R, Xiong H, Ye F, Zeng C, Fu X, Li L. An IFNgamma\/STAT1\/JMJD3 axis induces ZEB1 expression and promotes aggressiveness in lung adenocarcinoma. Mol Cancer Res. 2021;19:1234\u201346.","journal-title":"Mol Cancer Res"},{"key":"3323_CR61","doi-asserted-by":"publisher","first-page":"6847","DOI":"10.7150\/thno.51864","volume":"11","author":"J Xun","year":"2021","unstructured":"Xun J, Du L, Gao R, Shen L, Wang D, Kang L, Chen C, Zhang Z, Zhang Y, Yue S, et al. Cancer-derived Exosomal miR-138-5p modulates polarization of tumor-associated macrophages through Inhibition of KDM6B. Theranostics. 2021;11:6847\u201359.","journal-title":"Theranostics"},{"key":"3323_CR62","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","volume":"19","author":"SJ Hogg","year":"2020","unstructured":"Hogg SJ, Beavis PA, Dawson MA, Johnstone RW. Targeting the epigenetic regulation of antitumour immunity. Nat Rev Drug Discov. 2020;19:776\u2013800.","journal-title":"Nat Rev Drug Discov"},{"key":"3323_CR63","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jacc.2017.05.067","volume":"70","author":"P van der Harst","year":"2017","unstructured":"van der Harst P, de Windt LJ, Chambers JC. Translational perspective on epigenetics in cardiovascular disease. J Am Coll Cardiol. 2017;70:590\u2013606.","journal-title":"J Am Coll Cardiol"},{"key":"3323_CR64","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1093\/emboj\/17.17.4905","volume":"17","author":"A Razin","year":"1998","unstructured":"Razin A. CpG methylation, chromatin structure and gene silencing-a three-way connection. Embo J. 1998;17:4905\u20138.","journal-title":"Embo J"},{"key":"3323_CR65","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/HYPERTENSIONAHA.122.20796","volume":"80","author":"JK Kresovich","year":"2023","unstructured":"Kresovich JK, Sandler DP, Taylor JA. Methylation-Based biological age and hypertension prevalence and incidence. Hypertension. 2023;80:1213\u201322.","journal-title":"Hypertension"},{"key":"3323_CR66","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1161\/HYPERTENSIONAHA.118.11171","volume":"72","author":"M Liang","year":"2018","unstructured":"Liang M. Epigenetic mechanisms and hypertension. Hypertension. 2018;72:1244\u201354.","journal-title":"Hypertension"},{"key":"3323_CR67","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1161\/HYPERTENSIONAHA.122.19953","volume":"80","author":"X Hong","year":"2023","unstructured":"Hong X, Miao K, Cao W, Lv J, Yu C, Huang T, Sun D, Liao C, Pang Y, Pang Z, et al. Association between DNA methylation and blood pressure: A 5-Year longitudinal twin study. Hypertension. 2023;80:169\u201381.","journal-title":"Hypertension"},{"key":"3323_CR68","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/HYPERTENSIONAHA.124.22072","volume":"81","author":"KN Pandey","year":"2024","unstructured":"Pandey KN. Genetic and epigenetic mechanisms regulating blood pressure and kidney dysfunction. Hypertension. 2024;81:1424\u201337.","journal-title":"Hypertension"},{"key":"3323_CR69","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1161\/CIRCRESAHA.124.324455","volume":"135","author":"D Huang","year":"2024","unstructured":"Huang D, Shang W, Xu M, Wan Q, Zhang J, Tang X, Shen Y, Wang Y, Yu Y. Genome-Wide methylation analysis reveals a KCNK3-Prominent causal cascade on hypertension. Circ Res. 2024;135:e76\u201393.","journal-title":"Circ Res"},{"key":"3323_CR70","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41420-022-01152-9","volume":"8","author":"G Lin","year":"2022","unstructured":"Lin G, Lin L, Lin H, Chen W, Chen L, Chen X, Chen S, Lin Q, Xu Y, Zeng Y. KCNK3 inhibits proliferation and glucose metabolism of lung adenocarcinoma via activation of AMPK-TXNIP pathway. Cell Death Discov. 2022;8:360.","journal-title":"Cell Death Discov"},{"key":"3323_CR71","first-page":"3743","volume":"63","author":"DH Kim","year":"2003","unstructured":"Kim DH, Kim JS, Ji YI, Shim YM, Kim H, Han J, Park J. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Cancer Res. 2003;63:3743\u20136.","journal-title":"Cancer Res"},{"key":"3323_CR72","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1158\/0008-5472.CAN-17-2466","volume":"78","author":"ML Schmidt","year":"2018","unstructured":"Schmidt ML, Hobbing KR, Donninger H, Clark GJ. RASSF1A deficiency enhances RAS-Driven lung tumorigenesis. Cancer Res. 2018;78:2614\u201323.","journal-title":"Cancer Res"},{"key":"3323_CR73","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1158\/0008-5472.CAN-05-3813","volume":"66","author":"JS Kim","year":"2006","unstructured":"Kim JS, Kim JW, Han J, Shim YM, Park J, Kim DH. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer. Cancer Res. 2006;66:4049\u201354.","journal-title":"Cancer Res"},{"key":"3323_CR74","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1056\/NEJMc080835","volume":"358","author":"S Toyooka","year":"2008","unstructured":"Toyooka S, Matsuo K, Gazdar AF. DNA methylation in lung cancer. N Engl J Med. 2008;358:2513. author reply 2514.","journal-title":"N Engl J Med"},{"key":"3323_CR75","doi-asserted-by":"crossref","unstructured":"Welch CL, Chung WK. Channelopathy genes in pulmonary arterial hypertension. Biomolecules 2022, 12.","DOI":"10.3390\/biom12020265"},{"key":"3323_CR76","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1016\/S2666-7568(21)00061-1","volume":"2","author":"J Pedro Ferreira","year":"2021","unstructured":"Pedro Ferreira J, Pitt B, Zannad F. Histone deacetylase inhibitors for cardiovascular conditions and healthy longevity. Lancet Healthy Longev. 2021;2:e371\u20139.","journal-title":"Lancet Healthy Longev"},{"key":"3323_CR77","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1161\/CIRCRESAHA.118.314032","volume":"124","author":"J Guo","year":"2019","unstructured":"Guo J, Wang Z, Wu J, Liu M, Li M, Sun Y, Huang W, Li Y, Zhang Y, Tang W, et al. Endothelial SIRT6 is vital to prevent hypertension and associated cardiorenal injury through targeting Nkx3.2-GATA5 signaling. Circ Res. 2019;124:1448\u201361.","journal-title":"Circ Res"},{"key":"3323_CR78","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/HYPERTENSIONAHA.110.154567","volume":"56","author":"JP Cardinale","year":"2010","unstructured":"Cardinale JP, Sriramula S, Pariaut R, Guggilam A, Mariappan N, Elks CM, Francis J. HDAC Inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats. Hypertension. 2010;56:437\u201344.","journal-title":"Hypertension"},{"key":"3323_CR79","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/ijo.2017.166","volume":"41","author":"J Choi","year":"2017","unstructured":"Choi J, Park S, Kwon TK, Sohn SI, Park KM, Kim JI. Role of the histone deacetylase inhibitor valproic acid in high-fat diet-induced hypertension via Inhibition of HDAC1\/angiotensin II axis. Int J Obes (Lond). 2017;41:1702\u20139.","journal-title":"Int J Obes (Lond)"},{"key":"3323_CR80","doi-asserted-by":"publisher","first-page":"105695","DOI":"10.1016\/j.phrs.2021.105695","volume":"170","author":"MG Shetty","year":"2021","unstructured":"Shetty MG, Pai P, Deaver RE, Satyamoorthy K, Babitha KS. Histone deacetylase 2 selective inhibitors: A versatile therapeutic strategy as next generation drug target in cancer therapy. Pharmacol Res. 2021;170:105695.","journal-title":"Pharmacol Res"},{"key":"3323_CR81","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.lungcan.2013.08.010","volume":"82","author":"N Shirsath","year":"2013","unstructured":"Shirsath N, Rathos M, Chaudhari U, Sivaramakrishnan H, Joshi K. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines. Lung Cancer. 2013;82:214\u201321.","journal-title":"Lung Cancer"},{"key":"3323_CR82","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1158\/2159-8290.CD-16-0800","volume":"6","author":"AE Frankel","year":"2016","unstructured":"Frankel AE, Liu X, Minna JD. Developing EZH2-Targeted therapy for lung cancer. Cancer Discov. 2016;6:949\u201352.","journal-title":"Cancer Discov"},{"key":"3323_CR83","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12943-015-0302-8","volume":"14","author":"AM Rusek","year":"2015","unstructured":"Rusek AM, Abba M, Eljaszewicz A, Moniuszko M, Niklinski J, Allgayer H. MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer. Mol Cancer. 2015;14:34.","journal-title":"Mol Cancer"},{"key":"3323_CR84","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4161\/cc.6.9.4209","volume":"6","author":"B Weber","year":"2007","unstructured":"Weber B, Stresemann C, Brueckner B, Lyko F. Methylation of human MicroRNA genes in normal and neoplastic cells. Cell Cycle. 2007;6:1001\u20135.","journal-title":"Cell Cycle"},{"key":"3323_CR85","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1158\/1541-7786.MCR-10-0052","volume":"8","author":"P Ceppi","year":"2010","unstructured":"Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti GV, Papotti M, Allgayer H. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res. 2010;8:1207\u201316.","journal-title":"Mol Cancer Res"},{"key":"3323_CR86","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1161\/ATVBAHA.111.226670","volume":"31","author":"BN Davis-Dusenbery","year":"2011","unstructured":"Davis-Dusenbery BN, Wu C, Hata A. Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler Thromb Vasc Biol. 2011;31:2370\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3323_CR87","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/cvr\/cvad089","volume":"119","author":"X Jiao","year":"2023","unstructured":"Jiao X, Yu H, Du Z, Li L, Hu C, Du Y, Zhang J, Zhang X, Lv Q, Li F, et al. Vascular smooth muscle cells specific deletion of angiopoietin-like protein 8 prevents angiotensin II-promoted hypertension and cardiovascular hypertrophy. Cardiovasc Res. 2023;119:1856\u201368.","journal-title":"Cardiovasc Res"},{"key":"3323_CR88","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1161\/CIRCRESAHA.112.267591","volume":"111","author":"P Caruso","year":"2012","unstructured":"Caruso P, Dempsie Y, Stevens HC, McDonald RA, Long L, Lu R, White K, Mair KM, McClure JD, Southwood M, et al. A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circ Res. 2012;111:290\u2013300.","journal-title":"Circ Res"},{"key":"3323_CR89","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/CIRCRESAHA.115.306806","volume":"117","author":"L Deng","year":"2015","unstructured":"Deng L, Blanco FJ, Stevens H, Lu R, Caudrillier A, McBride M, McClure JD, Grant J, Thomas M, Frid M, et al. MicroRNA-143 activation regulates smooth muscle and endothelial cell crosstalk in pulmonary arterial hypertension. Circ Res. 2015;117:870\u201383.","journal-title":"Circ Res"},{"key":"3323_CR90","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1158\/2159-8290.CD-15-0854","volume":"6","author":"N Dimitrova","year":"2016","unstructured":"Dimitrova N, Gocheva V, Bhutkar A, Resnick R, Jong RM, Miller KM, Bendor J, Jacks T. Stromal expression of miR-143\/145 promotes neoangiogenesis in lung cancer development. Cancer Discov. 2016;6:188\u2013201.","journal-title":"Cancer Discov"},{"key":"3323_CR91","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11906-011-0235-6","volume":"14","author":"S B\u00e1tkai","year":"2012","unstructured":"B\u00e1tkai S, Thum T. MicroRNAs in hypertension: mechanisms and therapeutic targets. Curr Hypertens Rep. 2012;14:79\u201387.","journal-title":"Curr Hypertens Rep"},{"key":"3323_CR92","doi-asserted-by":"publisher","first-page":"e00812","DOI":"10.1002\/prp2.812","volume":"9","author":"Y Liu","year":"2021","unstructured":"Liu Y, Li C, Liu H, Wang J. Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p\/GRK5 axis. Pharmacol Res Perspect. 2021;9:e00812.","journal-title":"Pharmacol Res Perspect"},{"key":"3323_CR93","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/tox.24004","volume":"39","author":"B Yang","year":"2024","unstructured":"Yang B, Yao L, Yang L, Zhao F, Zhou W. Inhibition of miR-578 through SOCS2-dependent manner reverses gefitinib resistance in NSCLC cells. Environ Toxicol. 2024;39:1283\u201393.","journal-title":"Environ Toxicol"},{"key":"3323_CR94","doi-asserted-by":"publisher","first-page":"657053","DOI":"10.3389\/fphar.2021.657053","volume":"12","author":"B Yang","year":"2021","unstructured":"Yang B, Zhao F, Yao L, Zong Z, Xiao L. CircRNA circ_0006677 inhibits the progression and Glycolysis in Non-Small-Cell lung cancer by sponging miR-578 and regulating SOCS2 expression. Front Pharmacol. 2021;12:657053.","journal-title":"Front Pharmacol"},{"key":"3323_CR95","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.7150\/ijbs.109593","volume":"21","author":"S Cui","year":"2025","unstructured":"Cui S, Peng Q, Ma Q, Xu X, Zhang W, Jiang X, Tan S, Yang W, Han Y, Oyang L, et al. Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significance. Int J Biol Sci. 2025;21:2991\u20133010.","journal-title":"Int J Biol Sci"},{"key":"3323_CR96","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nrneph.2016.51","volume":"12","author":"JM Lorenzen","year":"2016","unstructured":"Lorenzen JM, Thum T. Long noncoding RNAs in kidney and cardiovascular diseases. Nat Rev Nephrol. 2016;12:360\u201373.","journal-title":"Nat Rev Nephrol"},{"key":"3323_CR97","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.7150\/thno.26024","volume":"8","author":"B Yu","year":"2018","unstructured":"Yu B, Wang S. Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease. Theranostics. 2018;8:3654\u201375.","journal-title":"Theranostics"},{"key":"3323_CR98","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/cvr\/cvaa050","volume":"116","author":"KR Zahid","year":"2020","unstructured":"Zahid KR, Raza U, Chen J, Raj UJ, Gou D. Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs. Cardiovasc Res. 2020;116:1937\u201347.","journal-title":"Cardiovasc Res"},{"key":"3323_CR99","doi-asserted-by":"publisher","first-page":"174","DOI":"10.7150\/jca.65031","volume":"13","author":"Z Cao","year":"2022","unstructured":"Cao Z, Oyang L, Luo X, Xia L, Hu J, Lin J, Tan S, Tang Y, Zhou Y, Cao D, Liao Q. The roles of long non-coding RNAs in lung cancer. J Cancer. 2022;13:174\u201383.","journal-title":"J Cancer"},{"key":"3323_CR100","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1161\/CIRCULATIONAHA.120.047626","volume":"142","author":"J Omura","year":"2020","unstructured":"Omura J, Habbout K, Shimauchi T, Wu WH, Breuils-Bonnet S, Tremblay E, Martineau S, Nadeau V, Gagnon K, Mazoyer F, et al. Identification of long noncoding RNA H19 as a new biomarker and therapeutic target in right ventricular failure in pulmonary arterial hypertension. Circulation. 2020;142:1464\u201384.","journal-title":"Circulation"},{"key":"3323_CR101","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1158\/0008-5472.CAN-06-0037","volume":"66","author":"D Barsyte-Lovejoy","year":"2006","unstructured":"Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 2006;66:5330\u20137.","journal-title":"Cancer Res"},{"key":"3323_CR102","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/HYPERTENSIONAHA.116.07259","volume":"68","author":"YN Wang","year":"2016","unstructured":"Wang YN, Shan K, Yao MD, Yao J, Wang JJ, Li X, Liu B, Zhang YY, Ji Y, Jiang Q, Yan B. Long noncoding RNA-GAS5: A novel regulator of Hypertension-Induced vascular remodeling. Hypertension. 2016;68:736\u201348.","journal-title":"Hypertension"},{"key":"3323_CR103","doi-asserted-by":"publisher","first-page":"2476175","DOI":"10.1155\/2019\/2476175","volume":"2019","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, Dai X, Yang T, Zhang N, Liu Z, Jiang Y. Low long noncoding RNA growth Arrest-Specific transcript 5 expression in the exosomes of lung cancer cells promotes tumor angiogenesis. J Oncol. 2019;2019:2476175.","journal-title":"J Oncol"},{"key":"3323_CR104","doi-asserted-by":"crossref","unstructured":"Lambrou GI, Hatziagapiou K, Zaravinos A. The Non-Coding RNA GAS5 and its role in tumor Therapy-Induced resistance. Int J Mol Sci 2020, 21.","DOI":"10.3390\/ijms21207633"},{"key":"3323_CR105","doi-asserted-by":"publisher","first-page":"175220","DOI":"10.1016\/j.ejphar.2022.175220","volume":"931","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard S, Shirvani-Farsani Z, Hussen BM, Taheri M, Samsami M. The key roles of non-coding RNAs in the pathophysiology of hypertension. Eur J Pharmacol. 2022;931:175220.","journal-title":"Eur J Pharmacol"},{"key":"3323_CR106","doi-asserted-by":"publisher","first-page":"31093","DOI":"10.1038\/srep31093","volume":"6","author":"Y Wu","year":"2016","unstructured":"Wu Y, Lyu H, Liu H, Shi X, Song Y, Liu B. Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer. Sci Rep. 2016;6:31093.","journal-title":"Sci Rep"},{"key":"3323_CR107","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2174\/1386207326666230913120523","volume":"27","author":"W Jiang","year":"2024","unstructured":"Jiang W, Zhu X, Bo J, Ma J. Screening of Immune-related LncRNAs in lung adenocarcinoma and Establishing a survival prognostic risk prediction model. Comb Chem High Throughput Screen. 2024;27:1175\u201390.","journal-title":"Comb Chem High Throughput Screen"},{"key":"3323_CR108","doi-asserted-by":"publisher","first-page":"e09521","DOI":"10.1016\/j.heliyon.2022.e09521","volume":"8","author":"Q Xue","year":"2022","unstructured":"Xue Q, Wang Y, Zheng Q, Chen L, Jin Y, Shen X, Li Y. Construction of a prognostic immune-related LncRNA model and identification of the immune microenvironment in middle- or advanced-stage lung squamous carcinoma patients. Heliyon. 2022;8:e09521.","journal-title":"Heliyon"},{"key":"3323_CR109","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1002\/ctm2.388","volume":"11","author":"C Tan","year":"2021","unstructured":"Tan C, Zhang H, Yu D, Hu Y, Wang P, Wang D, Fa J, Ran H, Zhang X, Chen Y, et al. A genome-wide association study identifies novel association between genetic variants in GGT7 and LINC00944 and hypertension. Clin Transl Med. 2021;11:e388.","journal-title":"Clin Transl Med"},{"key":"3323_CR110","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12967-023-04190-8","volume":"21","author":"K Li","year":"2023","unstructured":"Li K, Gong Q, Xiang XD, Guo G, Liu J, Zhao L, Li J, Chen N, Li H, Zhang LJ, et al. HNRNPA2B1-mediated m(6)A modification of LncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p\/PTEN axis. J Transl Med. 2023;21:382.","journal-title":"J Transl Med"},{"key":"3323_CR111","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.ymthe.2019.07.022","volume":"27","author":"Y Xing","year":"2019","unstructured":"Xing Y, Zheng X, Fu Y, Qi J, Li M, Ma M, Wang S, Li S, Zhu D. Long noncoding RNA-Maternally expressed gene 3 contributes to hypoxic pulmonary hypertension. Mol Ther. 2019;27:2166\u201381.","journal-title":"Mol Ther"},{"key":"3323_CR112","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1161\/HYPERTENSIONAHA.111.00776","volume":"62","author":"J Zou","year":"2013","unstructured":"Zou J, Li Y, Yan CH, Wei FF, Zhang L, Wang JG. Blood pressure in relation to interactions between sodium dietary intake and renal handling. Hypertension. 2013;62:719\u201325.","journal-title":"Hypertension"},{"key":"3323_CR113","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.cell.2019.06.005","volume":"178","author":"C Wiel","year":"2019","unstructured":"Wiel C, Le Gal K, Ibrahim MX, Jahangir CA, Kashif M, Yao H, Ziegler DV, Xu X, Ghosh T, Mondal T, et al. BACH1 stabilization by antioxidants stimulates lung cancer metastasis. Cell. 2019;178:330\u2013e345322.","journal-title":"Cell"},{"key":"3323_CR114","doi-asserted-by":"publisher","first-page":"221ra215","DOI":"10.1126\/scitranslmed.3007653","volume":"6","author":"VI Sayin","year":"2014","unstructured":"Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014;6:221ra215.","journal-title":"Sci Transl Med"},{"key":"3323_CR115","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1289\/ehp.1409004","volume":"123","author":"J Jiang","year":"2015","unstructured":"Jiang J, Liu M, Parvez F, Wang B, Wu F, Eunus M, Bangalore S, Newman JD, Ahmed A, Islam T, et al. Association between arsenic exposure from drinking water and longitudinal change in blood pressure among HEALS cohort participants. Environ Health Perspect. 2015;123:806\u201312.","journal-title":"Environ Health Perspect"},{"key":"3323_CR116","doi-asserted-by":"publisher","first-page":"087001","DOI":"10.1289\/EHP577","volume":"125","author":"CC Kuo","year":"2017","unstructured":"Kuo CC, Moon KA, Wang SL, Silbergeld E, Navas-Acien A. The association of arsenic metabolism with cancer, cardiovascular disease, and diabetes: A systematic review of the epidemiological evidence. Environ Health Perspect. 2017;125:087001.","journal-title":"Environ Health Perspect"},{"key":"3323_CR117","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.envres.2016.11.016","volume":"153","author":"EM Hall","year":"2017","unstructured":"Hall EM, Acevedo J, L\u00f3pez FG, Cort\u00e9s S, Ferreccio C, Smith AH, Steinmaus CM. Hypertension among adults exposed to drinking water arsenic in Northern Chile. Environ Res. 2017;153:99\u2013105.","journal-title":"Environ Res"},{"key":"3323_CR118","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1016\/j.scitotenv.2011.07.058","volume":"409","author":"SL Wang","year":"2011","unstructured":"Wang SL, Li WF, Chen CJ, Huang YL, Chen JW, Chang KH, Tsai LY, Chou KM. Hypertension incidence after tap-water implementation: a 13-year follow-up study in the arseniasis-endemic area of Southwestern Taiwan. Sci Total Environ. 2011;409:4528\u201335.","journal-title":"Sci Total Environ"},{"key":"3323_CR119","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0140-6736(75)90054-9","volume":"2","author":"WJ Blot","year":"1975","unstructured":"Blot WJ, Fraumeni JF Jr. Arsenical air pollution and lung cancer. Lancet. 1975;2:142\u20134.","journal-title":"Lancet"},{"key":"3323_CR120","doi-asserted-by":"publisher","first-page":"A378","DOI":"10.1289\/ehp.113-a378","volume":"113","author":"MN Mead","year":"2005","unstructured":"Mead MN. Arsenic: in search of an antidote to a global poison. Environ Health Perspect. 2005;113:A378\u2013386.","journal-title":"Environ Health Perspect"},{"key":"3323_CR121","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1289\/ehp.9297259","volume":"97","author":"AH Smith","year":"1992","unstructured":"Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ, Smith MT. Cancer risks from arsenic in drinking water. Environ Health Perspect. 1992;97:259\u201367.","journal-title":"Environ Health Perspect"},{"key":"3323_CR122","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1158\/1055-9965.638.13.4","volume":"13","author":"HR Guo","year":"2004","unstructured":"Guo HR, Wang NS, Hu H, Monson RR. Cell type specificity of lung cancer associated with arsenic ingestion. Cancer Epidemiol Biomarkers Prev. 2004;13:638\u201343.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3323_CR123","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/toxsci\/kfj159","volume":"91","author":"X Cui","year":"2006","unstructured":"Cui X, Wakai T, Shirai Y, Hatakeyama K, Hirano S. Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A\/J mice. Toxicol Sci. 2006;91:372\u201381.","journal-title":"Toxicol Sci"},{"key":"3323_CR124","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1383-5742(97)00008-2","volume":"386","author":"MJ Mass","year":"1997","unstructured":"Mass MJ, Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res. 1997;386:263\u201377.","journal-title":"Mutat Res"},{"key":"3323_CR125","doi-asserted-by":"publisher","first-page":"10907","DOI":"10.1073\/pnas.94.20.10907","volume":"94","author":"CQ Zhao","year":"1997","unstructured":"Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci U S A. 1997;94:10907\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3323_CR126","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/carcin\/bgn102","volume":"29","author":"TJ Jensen","year":"2008","unstructured":"Jensen TJ, Novak P, Eblin KE, Gandolfi AJ, Futscher BW. Epigenetic remodeling during arsenical-induced malignant transformation. Carcinogenesis. 2008;29:1500\u20138.","journal-title":"Carcinogenesis"},{"key":"3323_CR127","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/carcin\/bgn063","volume":"29","author":"X Zhou","year":"2008","unstructured":"Zhou X, Sun H, Ellen TP, Chen H, Costa M. Arsenite alters global histone H3 methylation. Carcinogenesis. 2008;29:1831\u20136.","journal-title":"Carcinogenesis"},{"key":"3323_CR128","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/S0140-6736(95)90110-8","volume":"345","author":"NM Kaplan","year":"1995","unstructured":"Kaplan NM. Alcohol and hypertension. Lancet. 1995;345:1588\u20139.","journal-title":"Lancet"},{"key":"3323_CR129","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.jacc.2005.02.075","volume":"45","author":"DL Lucas","year":"2005","unstructured":"Lucas DL, Brown RA, Wassef M, Giles TD. Alcohol and the cardiovascular system: research challenges and opportunities. J Am Coll Cardiol. 2005;45:1916\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"3323_CR130","first-page":"Iii41","volume":"64","author":"RB Wallace","year":"1981","unstructured":"Wallace RB, Lynch CF, Pomrehn PR, Criqui MH, Heiss G. Alcohol and hypertension: epidemiologic and experimental considerations. Lipid Res Clin Program Circulation. 1981;64:Iii41\u201347.","journal-title":"Lipid Res Clin Program Circulation"},{"key":"3323_CR131","doi-asserted-by":"publisher","first-page":"eaay5034","DOI":"10.1126\/sciadv.aay5034","volume":"6","author":"A Thompson","year":"2020","unstructured":"Thompson A, Cook J, Choquet H, Jorgenson E, Yin J, Kinnunen T, Barclay J, Morris AP, Pirmohamed M. Functional validity, role, and implications of heavy alcohol consumption genetic loci. Sci Adv. 2020;6:eaay5034.","journal-title":"Sci Adv"},{"key":"3323_CR132","doi-asserted-by":"publisher","first-page":"e223849","DOI":"10.1001\/jamanetworkopen.2022.3849","volume":"5","author":"KJ Biddinger","year":"2022","unstructured":"Biddinger KJ, Emdin CA, Haas ME, Wang M, Hindy G, Ellinor PT, Kathiresan S, Khera AV, Aragam KG. Association of habitual alcohol intake with risk of cardiovascular disease. JAMA Netw Open. 2022;5:e223849.","journal-title":"JAMA Netw Open"},{"key":"3323_CR133","first-page":"797","volume":"330","author":"E Harris","year":"2023","unstructured":"Harris E. Even without hypertension, daily alcohol May increase blood pressure. JAMA. 2023;330:797.","journal-title":"JAMA"},{"key":"3323_CR134","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1470-2045(06)70577-0","volume":"7","author":"P Boffetta","year":"2006","unstructured":"Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol. 2006;7:149\u201356.","journal-title":"Lancet Oncol"},{"key":"3323_CR135","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.medcli.2016.12.033","volume":"148","author":"SM \u00c1lvarez-Avell\u00f3n","year":"2017","unstructured":"\u00c1lvarez-Avell\u00f3n SM, Fern\u00e1ndez-Somoano A, Navarrete-Mu\u00f1oz EM, Vioque J, Tard\u00f3n A. Effect of alcohol and its metabolites in lung cancer: CAPUA study. Med Clin (Barc). 2017;148:531\u20138.","journal-title":"Med Clin (Barc)"},{"key":"3323_CR136","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nrc2674","volume":"9","author":"SS Hecht","year":"2009","unstructured":"Hecht SS, Kassie F, Hatsukami DK. Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers. Nat Rev Cancer. 2009;9:476\u201388.","journal-title":"Nat Rev Cancer"},{"key":"3323_CR137","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.critrevonc.2008.01.004","volume":"66","author":"JM Lee","year":"2008","unstructured":"Lee JM, Yanagawa J, Peebles KA, Sharma S, Mao JT, Dubinett SM. Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment. Crit Rev Oncol Hematol. 2008;66:208\u201317.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3323_CR138","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/08958370600742821","volume":"18","author":"CJ Smith","year":"2006","unstructured":"Smith CJ, Perfetti TA, King JA. Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhal Toxicol. 2006;18:667\u201377.","journal-title":"Inhal Toxicol"},{"key":"3323_CR139","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1183\/09031936.00033310","volume":"36","author":"RP Young","year":"2010","unstructured":"Young RP, Whittington CF, Hopkins RJ, Hay BA, Epton MJ, Black PN, Gamble GD. Chromosome 4q31 locus in COPD is also associated with lung cancer. Eur Respir J. 2010;36:1375\u201382.","journal-title":"Eur Respir J"},{"key":"3323_CR140","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/annonc\/mdt418","volume":"25","author":"M Beau-Faller","year":"2014","unstructured":"Beau-Faller M, Prim N, Ruppert AM, Nanni-Met\u00e9llus I, Lacave R, Lacroix L, Escande F, Lizard S, Pretet JL, Rouquette I, et al. Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network. Ann Oncol. 2014;25:126\u201331.","journal-title":"Ann Oncol"},{"key":"3323_CR141","doi-asserted-by":"publisher","first-page":"e0247620","DOI":"10.1371\/journal.pone.0247620","volume":"16","author":"H Burnett","year":"2021","unstructured":"Burnett H, Emich H, Carroll C, Stapleton N, Mahadevia P, Li T. Epidemiological and clinical burden of EGFR exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review. PLoS ONE. 2021;16:e0247620.","journal-title":"PLoS ONE"},{"key":"3323_CR142","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/JTO.0b013e3182779d18","volume":"8","author":"GR Oxnard","year":"2013","unstructured":"Oxnard GR, Lo PC, Nishino M, Dahlberg SE, Lindeman NI, Butaney M, Jackman DM, Johnson BE, J\u00e4nne PA. Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions. J Thorac Oncol. 2013;8:179\u201384.","journal-title":"J Thorac Oncol"},{"key":"3323_CR143","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41571-023-00844-0","volume":"21","author":"J LoPiccolo","year":"2024","unstructured":"LoPiccolo J, Gusev A, Christiani DC, J\u00e4nne PA. Lung cancer in patients who have never smoked - an emerging disease. Nat Rev Clin Oncol. 2024;21:121\u201346.","journal-title":"Nat Rev Clin Oncol"},{"key":"3323_CR144","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1158\/0008-5472.CAN-12-4033","volume":"73","author":"X Wu","year":"2013","unstructured":"Wu X, Wang L, Ye Y, Aakre JA, Pu X, Chang GC, Yang PC, Roth JA, Marks RS, Lippman SM, et al. Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers. Cancer Res. 2013;73:4028\u201338.","journal-title":"Cancer Res"},{"key":"3323_CR145","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/01.HYP.0000028490.77489.0C","volume":"40","author":"M Abe","year":"2002","unstructured":"Abe M, Nakura J, Yamamoto M, Jin JJ, Wu Z, Tabara Y, Yamamoto Y, Igase M, Kohara K, Miki T. Association of GNAS1 gene variant with hypertension depending on smoking status. Hypertension. 2002;40:261\u20135.","journal-title":"Hypertension"},{"key":"3323_CR146","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/HJH.0b013e32831ef54f","volume":"27","author":"ME Montasser","year":"2009","unstructured":"Montasser ME, Shimmin LC, Hanis CL, Boerwinkle E, Hixson JE. Gene by smoking interaction in hypertension: identification of a major quantitative trait locus on chromosome 15q for systolic blood pressure in Mexican-Americans. J Hypertens. 2009;27:491\u2013501.","journal-title":"J Hypertens"},{"key":"3323_CR147","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S0140-6736(02)11274-8","volume":"360","author":"B Brunekreef","year":"2002","unstructured":"Brunekreef B, Holgate ST. Air pollution and health. Lancet. 2002;360:1233\u201342.","journal-title":"Lancet"},{"key":"3323_CR148","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1164\/rccm.202107-1770OC","volume":"206","author":"I Cheng","year":"2022","unstructured":"Cheng I, Yang J, Tseng C, Wu J, Shariff-Marco S, Park SL, Conroy SM, Inamdar PP, Fruin S, Larson T, et al. Traffic-related air pollution and lung cancer incidence: the California multiethnic cohort study. Am J Respir Crit Care Med. 2022;206:1008\u201318.","journal-title":"Am J Respir Crit Care Med"},{"key":"3323_CR149","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1164\/rccm.202011-4063OC","volume":"204","author":"Y Huang","year":"2021","unstructured":"Huang Y, Zhu M, Ji M, Fan J, Xie J, Wei X, Jiang X, Xu J, Chen L, Yin R, et al. Air pollution, genetic factors, and the risk of lung cancer: A prospective study in the UK biobank. Am J Respir Crit Care Med. 2021;204:817\u201325.","journal-title":"Am J Respir Crit Care Med"},{"key":"3323_CR150","doi-asserted-by":"publisher","first-page":"e657","DOI":"10.1016\/S2542-5196(24)00168-2","volume":"8","author":"M Schwarz","year":"2024","unstructured":"Schwarz M, Peters A, Stafoggia M, de\u2019Donato F, Sera F, Bell ML, Guo Y, Honda Y, Huber V, Jaakkola JJK, et al. Temporal variations in the short-term effects of ambient air pollution on cardiovascular and respiratory mortality: a pooled analysis of 380 urban areas over a 22-year period. Lancet Planet Health. 2024;8:e657\u201365.","journal-title":"Lancet Planet Health"},{"key":"3323_CR151","doi-asserted-by":"publisher","first-page":"6854","DOI":"10.1021\/acs.est.2c08092","volume":"57","author":"R Fan","year":"2023","unstructured":"Fan R, Xu L, Cui B, Li D, Sun X, Qi Y, Rao J, Wang K, Wang C, Zhao K, et al. Genomic characterization revealed PM(2.5)-Associated mutational signatures in lung cancer including activation of APOBEC3B. Environ Sci Technol. 2023;57:6854\u201364.","journal-title":"Environ Sci Technol"},{"key":"3323_CR152","first-page":"1543","volume":"329","author":"E Harris","year":"2023","unstructured":"Harris E. Research shows air pollution promotes lung cancer. JAMA. 2023;329:1543.","journal-title":"JAMA"},{"key":"3323_CR153","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1016\/S1470-2045(22)00569-1","volume":"23","author":"E Gourd","year":"2022","unstructured":"Gourd E. New evidence that air pollution contributes substantially to lung cancer. Lancet Oncol. 2022;23:e448.","journal-title":"Lancet Oncol"},{"key":"3323_CR154","doi-asserted-by":"publisher","first-page":"122561","DOI":"10.1016\/j.envpol.2023.122561","volume":"337","author":"P Rajasekar","year":"2023","unstructured":"Rajasekar P, Hall RJ, Binaya KC, Mahapatra PS, Puppala SP, Thakker D, MacIsaac JL, Lin D, Kobor M, Bolton CE, et al. Nepalese indoor cookstove smoke extracts alter human airway epithelial gene expression, DNA methylation and hydroxymethylation. Environ Pollut. 2023;337:122561.","journal-title":"Environ Pollut"},{"key":"3323_CR155","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/EDE.0b013e3181d5e19b","volume":"21","author":"RJ Delfino","year":"2010","unstructured":"Delfino RJ, Tjoa T, Gillen DL, Staimer N, Polidori A, Arhami M, Jamner L, Sioutas C, Longhurst J. Traffic-related air pollution and blood pressure in elderly subjects with coronary artery disease. Epidemiology. 2010;21:396\u2013404.","journal-title":"Epidemiology"},{"key":"3323_CR156","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/CIRCULATIONAHA.111.052753","volume":"125","author":"PF Coogan","year":"2012","unstructured":"Coogan PF, White LF, Jerrett M, Brook RD, Su JG, Seto E, Burnett R, Palmer JR, Rosenberg L. Air pollution and incidence of hypertension and diabetes mellitus in black women living in Los Angeles. Circulation. 2012;125:767\u201372.","journal-title":"Circulation"},{"key":"3323_CR157","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.116.07218","volume":"68","author":"Y Cai","year":"2016","unstructured":"Cai Y, Zhang B, Ke W, Feng B, Lin H, Xiao J, Zeng W, Li X, Tao J, Yang Z, et al. Associations of Short-Term and Long-Term exposure to ambient air pollutants with hypertension: A systematic review and Meta-Analysis. Hypertension. 2016;68:62\u201370.","journal-title":"Hypertension"},{"key":"3323_CR158","doi-asserted-by":"publisher","first-page":"108041","DOI":"10.1016\/j.envint.2023.108041","volume":"178","author":"B Blechter","year":"2023","unstructured":"Blechter B, Cardenas A, Shi J, Wong JYY, Hu W, Rahman ML, Breeze C, Downward GS, Portengen L, Zhang Y, et al. Household air pollution and epigenetic aging in xuanwei, China. Environ Int. 2023;178:108041.","journal-title":"Environ Int"},{"key":"3323_CR159","doi-asserted-by":"publisher","first-page":"e13120","DOI":"10.1111\/ina.13120","volume":"32","author":"X Shan","year":"2022","unstructured":"Shan X, Tian X, Wang B, He L, Zhang L, Xue B, Liu C, Zheng L, Yu Y, Luo B. A global burden assessment of lung cancer attributed to residential radon exposure during 1990\u20132019. Indoor Air. 2022;32:e13120.","journal-title":"Indoor Air"},{"key":"3323_CR160","doi-asserted-by":"publisher","first-page":"57010","DOI":"10.1289\/EHP10669","volume":"130","author":"DB Richardson","year":"2022","unstructured":"Richardson DB, Rage E, Demers PA, Do MT, Fenske N, Deffner V, Kreuzer M, Samet J, Bertke SJ, Kelly-Reif K, et al. Lung cancer and radon: pooled analysis of uranium miners hired in 1960 or later. Environ Health Perspect. 2022;130:57010.","journal-title":"Environ Health Perspect"},{"key":"3323_CR161","doi-asserted-by":"publisher","first-page":"179569","DOI":"10.1016\/j.scitotenv.2025.179569","volume":"981","author":"L Martin-Gisbert","year":"2025","unstructured":"Martin-Gisbert L, Ruano-Ravina A, Garcia G, Pineiro-Lamas M, Garcia-Talavera M, Teijeiro A, Candal-Pedreira C. Duration versus intensity of exposure on the risk of lung cancer due to radon exposure in the general population. Sci Total Environ. 2025;981:179569.","journal-title":"Sci Total Environ"},{"key":"3323_CR162","doi-asserted-by":"publisher","first-page":"120307","DOI":"10.1016\/j.envres.2024.120307","volume":"264","author":"MS Lee","year":"2025","unstructured":"Lee MS, Eum KD, Li L, Iafrate J, Lanuti M, Koutrakis P, Christiani DC. Ambient beta particle radioactivity and lung cancer survival: results from the Boston lung cancer study. Environ Res. 2025;264:120307.","journal-title":"Environ Res"},{"key":"3323_CR163","first-page":"216","volume":"2","author":"K Zou","year":"2022","unstructured":"Zou K, Sun P, Huang H, Zhuo H, Qie R, Xie Y, Luo J, Li N, Li J, He J, et al. Etiology of lung cancer: evidence from epidemiologic studies. J Natl Cancer Cent. 2022;2:216\u201325.","journal-title":"J Natl Cancer Cent"},{"key":"3323_CR164","doi-asserted-by":"publisher","first-page":"106285","DOI":"10.1016\/j.envint.2020.106285","volume":"146","author":"S Papatheodorou","year":"2021","unstructured":"Papatheodorou S, Yao W, Vieira CLZ, Li L, Wylie BJ, Schwartz J, Koutrakis P. Residential radon exposure and hypertensive disorders of pregnancy in massachusetts, USA: A cohort study. Environ Int. 2021;146:106285.","journal-title":"Environ Int"},{"key":"3323_CR165","doi-asserted-by":"publisher","first-page":"104363","DOI":"10.1016\/j.critrevonc.2024.104363","volume":"198","author":"Y Liu","year":"2024","unstructured":"Liu Y, Xu Y, Xu W, He Z, Fu C, Du F. Radon and lung cancer: current status and future prospects. Crit Rev Oncol Hematol. 2024;198:104363.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3323_CR166","doi-asserted-by":"crossref","unstructured":"Riudavets M, Garcia de Herreros M, Besse B, Mezquita L. Radon and lung cancer: current trends and future perspectives. Cancers (Basel) 2022, 14.","DOI":"10.3390\/cancers14133142"},{"key":"3323_CR167","doi-asserted-by":"publisher","first-page":"120272","DOI":"10.1016\/j.envres.2024.120272","volume":"263","author":"M Angley","year":"2024","unstructured":"Angley M, Zhang Y, Koutrakis P, Kahe K. Exposure to radon and ambient particle radioactivity during pregnancy and adverse maternal, fetal and perinatal outcomes: the current literature and potential mechanisms. Environ Res. 2024;263:120272.","journal-title":"Environ Res"},{"key":"3323_CR168","doi-asserted-by":"publisher","first-page":"107478","DOI":"10.1016\/j.lungcan.2024.107478","volume":"189","author":"SM Fitzgerald","year":"2024","unstructured":"Fitzgerald SM. Resolving asbestos and ultrafine particulate definitions with carcinogenicity. Lung Cancer. 2024;189:107478.","journal-title":"Lung Cancer"},{"key":"3323_CR169","doi-asserted-by":"publisher","first-page":"107828","DOI":"10.1016\/j.lungcan.2024.107828","volume":"193","author":"AL Frank","year":"2024","unstructured":"Frank AL, van Zandwijk N. Asbestos history and use. Lung Cancer. 2024;193:107828.","journal-title":"Lung Cancer"},{"key":"3323_CR170","doi-asserted-by":"publisher","first-page":"107850","DOI":"10.1016\/j.lungcan.2024.107850","volume":"194","author":"M Metintas","year":"2024","unstructured":"Metintas M, Ak G, Metintas S. Environmental asbestos exposure and lung cancer. Lung Cancer. 2024;194:107850.","journal-title":"Lung Cancer"},{"key":"3323_CR171","doi-asserted-by":"publisher","first-page":"107849","DOI":"10.1016\/j.lungcan.2024.107849","volume":"195","author":"S Klebe","year":"2024","unstructured":"Klebe S, Rathi V, Russell PA. Lung cancer caused by asbestos: what a reporting pathologist needs to know. Lung Cancer. 2024;195:107849.","journal-title":"Lung Cancer"},{"key":"3323_CR172","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5271\/sjweh.4146","volume":"50","author":"B Jarvholm","year":"2024","unstructured":"Jarvholm B, Burdorf A. Asbestos and disease - a public health success story? Scand J Work Environ Health. 2024;50:53\u201360.","journal-title":"Scand J Work Environ Health"},{"key":"3323_CR173","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.pmedr.2015.10.005","volume":"2","author":"Y Rong","year":"2015","unstructured":"Rong Y, Luo X, Zhang Z, Cui X, Liu Y, Chen W. Occupational exposure to asbestos and cardiovascular related diseases: A meta-analysis. Prev Med Rep. 2015;2:920\u20136.","journal-title":"Prev Med Rep"},{"key":"3323_CR174","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/oemed-2011-100313","volume":"69","author":"AH Harding","year":"2012","unstructured":"Harding AH, Darnton A, Osman J. Cardiovascular disease mortality among British asbestos workers (1971\u20132005). Occup Environ Med. 2012;69:417\u201321.","journal-title":"Occup Environ Med"},{"key":"3323_CR175","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/oem.2006.029488","volume":"64","author":"K Toren","year":"2007","unstructured":"Toren K, Bergdahl IA, Nilsson T, Jarvholm B. Occupational exposure to particulate air pollution and mortality due to ischaemic heart disease and cerebrovascular disease. Occup Environ Med. 2007;64:515\u20139.","journal-title":"Occup Environ Med"},{"key":"3323_CR176","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.1111\/j.1582-4934.2008.00518.x","volume":"13","author":"P Boor","year":"2009","unstructured":"Boor P, Casper S, Celec P, Hurbankova M, Beno M, Heidland A, Amann K, Sebekova K. Renal, vascular and cardiac fibrosis in rats exposed to passive smoking and industrial dust fibre Amosite. J Cell Mol Med. 2009;13:4484\u201391.","journal-title":"J Cell Mol Med"},{"key":"3323_CR177","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1743-8977-4-4","volume":"4","author":"BT Mossman","year":"2007","unstructured":"Mossman BT, Borm PJ, Castranova V, Costa DL, Donaldson K, Kleeberger SR. Mechanisms of action of inhaled fibers, particles and nanoparticles in lung and cardiovascular diseases. Part Fibre Toxicol. 2007;4:4.","journal-title":"Part Fibre Toxicol"},{"key":"3323_CR178","doi-asserted-by":"crossref","unstructured":"Kang MS, Chae WR, Lee YJ, Moon KW. Occupational and environmental asbestos exposure and survival of patients with asbestos-Related cancer: A Follow-Up study on patients with malignant mesothelioma and asbestos-Related lung cancer in Korea. Toxics 2023, 12.","DOI":"10.3390\/toxics12010020"},{"issue":"Suppl 1","key":"3323_CR179","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2165\/00003495-199700531-00006","volume":"53","author":"CJ Ferro","year":"1997","unstructured":"Ferro CJ, Webb DJ. Endothelial dysfunction and hypertension. Drugs. 1997;53(Suppl 1):30\u201341.","journal-title":"Drugs"},{"key":"3323_CR180","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1164\/rccm.201304-0686PP","volume":"188","author":"JR Klinger","year":"2013","unstructured":"Klinger JR, Abman SH, Gladwin MT. Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013;188:639\u201346.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl D","key":"3323_CR181","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/eurheartj\/13.suppl_D.50","volume":"13","author":"TF L\u00fcscher","year":"1992","unstructured":"L\u00fcscher TF. Heterogeneity of endothelial dysfunction in hypertension. Eur Heart J. 1992;13(Suppl D):50\u20135.","journal-title":"Eur Heart J"},{"key":"3323_CR182","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1006\/jmcc.1998.0844","volume":"31","author":"JV Mombouli","year":"1999","unstructured":"Mombouli JV, Vanhoutte PM. Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol. 1999;31:61\u201374.","journal-title":"J Mol Cell Cardiol"},{"key":"3323_CR183","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1089\/ars.2007.1989","volume":"10","author":"E Schulz","year":"2008","unstructured":"Schulz E, Jansen T, Wenzel P, Daiber A, M\u00fcnzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal. 2008;10:1115\u201326.","journal-title":"Antioxid Redox Signal"},{"key":"3323_CR184","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1476-5381.2009.00240.x","volume":"157","author":"D Versari","year":"2009","unstructured":"Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S. Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol. 2009;157:527\u201336.","journal-title":"Br J Pharmacol"},{"key":"3323_CR185","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/sj.bjp.0706042","volume":"144","author":"PM Vanhoutte","year":"2005","unstructured":"Vanhoutte PM, Feletou M, Taddei S. Endothelium-dependent contractions in hypertension. Br J Pharmacol. 2005;144:449\u201358.","journal-title":"Br J Pharmacol"},{"key":"3323_CR186","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/jcp.31019","volume":"238","author":"D Aboukhater","year":"2023","unstructured":"Aboukhater D, Morad B, Nasrallah N, Nasser SA, Sahebkar A, Kobeissy F, Boudaka A, Eid AH. Inflammation and hypertension: underlying mechanisms and emerging Understandings. J Cell Physiol. 2023;238:1148\u201359.","journal-title":"J Cell Physiol"},{"key":"3323_CR187","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1089\/ars.2007.1998","volume":"10","author":"T Watson","year":"2008","unstructured":"Watson T, Goon PK, Lip GY. Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension. Antioxid Redox Signal. 2008;10:1079\u201388.","journal-title":"Antioxid Redox Signal"},{"key":"3323_CR188","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc.2017.51","volume":"17","author":"M De Palma","year":"2017","unstructured":"De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. 2017;17:457\u201374.","journal-title":"Nat Rev Cancer"},{"key":"3323_CR189","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/mc.20218","volume":"45","author":"F Houle","year":"2006","unstructured":"Houle F, Huot J. Dysregulation of the endothelial cellular response to oxidative stress in cancer. Mol Carcinog. 2006;45:362\u20137.","journal-title":"Mol Carcinog"},{"key":"3323_CR190","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12929-019-0580-3","volume":"26","author":"T Hsu","year":"2019","unstructured":"Hsu T, Nguyen-Tran HH, Trojanowska M. Active roles of dysfunctional vascular endothelium in fibrosis and cancer. J Biomed Sci. 2019;26:86.","journal-title":"J Biomed Sci"},{"key":"3323_CR191","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1476-4598-2-12","volume":"2","author":"JP Duffy","year":"2003","unstructured":"Duffy JP, Eibl G, Reber HA, Hines OJ. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer. 2003;2:12.","journal-title":"Mol Cancer"},{"key":"3323_CR192","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S1470-2045(01)00556-3","volume":"2","author":"M Toi","year":"2001","unstructured":"Toi M, Matsumoto T, Bando H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. Lancet Oncol. 2001;2:667\u201373.","journal-title":"Lancet Oncol"},{"key":"3323_CR193","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1593\/neo.05592","volume":"8","author":"PK Goon","year":"2006","unstructured":"Goon PK, Lip GY, Boos CJ, Stonelake PS, Blann AD. Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia. 2006;8:79\u201388.","journal-title":"Neoplasia"},{"key":"3323_CR194","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10456-008-9100-x","volume":"11","author":"JA Legg","year":"2008","unstructured":"Legg JA, Herbert JM, Clissold P, Bicknell R. Slits and roundabouts in cancer, tumour angiogenesis and endothelial cell migration. Angiogenesis. 2008;11:13\u201321.","journal-title":"Angiogenesis"},{"key":"3323_CR195","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","volume":"23","author":"DJ Hicklin","year":"2005","unstructured":"Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005;23:1011\u201327.","journal-title":"J Clin Oncol"},{"key":"3323_CR196","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1196\/annals.1413.021","volume":"1131","author":"S Das","year":"2008","unstructured":"Das S, Skobe M. Lymphatic vessel activation in cancer. Ann N Y Acad Sci. 2008;1131:235\u201341.","journal-title":"Ann N Y Acad Sci"},{"key":"3323_CR197","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ejso.2005.05.015","volume":"31","author":"RS Dua","year":"2005","unstructured":"Dua RS, Gui GP, Isacke CM. Endothelial adhesion molecules in breast cancer invasion into the vascular and lymphatic systems. Eur J Surg Oncol. 2005;31:824\u201332.","journal-title":"Eur J Surg Oncol"},{"key":"3323_CR198","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.lfs.2012.10.008","volume":"92","author":"FG Gomes","year":"2013","unstructured":"Gomes FG, Nedel F, Alves AM, N\u00f6r JE, Tarquinio SB. Tumor angiogenesis and lymphangiogenesis: tumor\/endothelial crosstalk and cellular\/microenvironmental signaling mechanisms. Life Sci. 2013;92:101\u20137.","journal-title":"Life Sci"},{"key":"3323_CR199","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1535-6108(03)00336-2","volume":"5","author":"MV Blagosklonny","year":"2004","unstructured":"Blagosklonny MV. Antiangiogenic therapy and tumor progression. Cancer Cell. 2004;5:13\u20137.","journal-title":"Cancer Cell"},{"key":"3323_CR200","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.pharep.2015.05.014","volume":"67","author":"A Blazejczyk","year":"2015","unstructured":"Blazejczyk A, Papiernik D, Porshneva K, Sadowska J, Wietrzyk J. Endothelium and cancer metastasis: perspectives for antimetastatic therapy. Pharmacol Rep. 2015;67:711\u20138.","journal-title":"Pharmacol Rep"},{"key":"3323_CR201","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13:759\u201371.","journal-title":"Nat Rev Cancer"},{"key":"3323_CR202","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41569-023-00964-1","volume":"21","author":"TJ Guzik","year":"2024","unstructured":"Guzik TJ, Nosalski R, Maffia P, Drummond GR. Immune and inflammatory mechanisms in hypertension. Nat Rev Cardiol. 2024;21:396\u2013416.","journal-title":"Nat Rev Cardiol"},{"key":"3323_CR203","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","volume":"77","author":"MS Garshick","year":"2021","unstructured":"Garshick MS, Ward NL, Krueger JG, Berger JS. Cardiovascular risk in patients with psoriasis: JACC review topic of the week. J Am Coll Cardiol. 2021;77:1670\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"3323_CR204","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/rheumatology\/kem169","volume":"46","author":"VF Panoulas","year":"2007","unstructured":"Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, Tselios AL, Metsios GS, Elisaf MS, Kitas GD. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford). 2007;46:1477\u201382.","journal-title":"Rheumatology (Oxford)"},{"key":"3323_CR205","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/cvr\/cvz201","volume":"116","author":"E Mu\u00f1oz Aguilera","year":"2020","unstructured":"Mu\u00f1oz Aguilera E, Suvan J, Buti J, Czesnikiewicz-Guzik M, Barbosa Ribeiro A, Orlandi M, Guzik TJ, Hingorani AD, Nart J, D\u2019Aiuto F. Periodontitis is associated with hypertension: a systematic review and meta-analysis. Cardiovasc Res. 2020;116:28\u201339.","journal-title":"Cardiovasc Res"},{"key":"3323_CR206","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.amjcard.2006.03.045","volume":"98","author":"JL Abramson","year":"2006","unstructured":"Abramson JL, Lewis C, Murrah NV, Anderson GT, Vaccarino V. Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults. Am J Cardiol. 2006;98:649\u201352.","journal-title":"Am J Cardiol"},{"key":"3323_CR207","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1161\/hy0202.104270","volume":"39","author":"JL Abramson","year":"2002","unstructured":"Abramson JL, Weintraub WS, Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension. 2002;39:197\u2013202.","journal-title":"Hypertension"},{"key":"3323_CR208","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/sj.jhh.1001785","volume":"19","author":"LE Bautista","year":"2005","unstructured":"Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005;19:149\u201354.","journal-title":"J Hum Hypertens"},{"key":"3323_CR209","doi-asserted-by":"publisher","first-page":"e001802","DOI":"10.1161\/JAHA.115.001802","volume":"4","author":"HD Sesso","year":"2015","unstructured":"Sesso HD, Jim\u00e9nez MC, Wang L, Ridker PM, Buring JE, Gaziano JM. Plasma inflammatory markers and the risk of developing hypertension in men. J Am Heart Assoc. 2015;4:e001802.","journal-title":"J Am Heart Assoc"},{"key":"3323_CR210","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1111\/bph.12876","volume":"171","author":"SM Krishnan","year":"2014","unstructured":"Krishnan SM, Sobey CG, Latz E, Mansell A, Drummond GR. IL-1\u03b2 and IL-18: inflammatory markers or mediators of hypertension? Br J Pharmacol. 2014;171:5589\u2013602.","journal-title":"Br J Pharmacol"},{"key":"3323_CR211","first-page":"192","volume":"6","author":"SW Rabkin","year":"2009","unstructured":"Rabkin SW. The role of Interleukin 18 in the pathogenesis of hypertension-induced vascular disease. Nat Clin Pract Cardiovasc Med. 2009;6:192\u20139.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"3323_CR212","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/HYPERTENSIONAHA.120.16437","volume":"78","author":"JM Thomas","year":"2021","unstructured":"Thomas JM, Ling YH, Huuskes B, Jelinic M, Sharma P, Saini N, Ferens DM, Diep H, Krishnan SM, Kemp-Harper BK, et al. IL-18 (Interleukin-18) produced by renal tubular epithelial cells promotes renal inflammation and injury during Deoxycorticosterone\/Salt-Induced hypertension in mice. Hypertension. 2021;78:1296\u2013309.","journal-title":"Hypertension"},{"key":"3323_CR213","doi-asserted-by":"publisher","first-page":"975367","DOI":"10.3389\/fimmu.2022.975367","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yang K, Chen F, Liu Q, Ni J, Cao W, Hua Y, He F, Liu Z, Li L, Fan G. Role of the CCL2-CCR2 axis in cardiovascular disease: pathogenesis and clinical implications. Front Immunol. 2022;13:975367.","journal-title":"Front Immunol"},{"key":"3323_CR214","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/HYPERTENSIONAHA.117.10145","volume":"71","author":"D Hevia","year":"2018","unstructured":"Hevia D, Araos P, Prado C, Fuentes Luppichini E, Rojas M, Alzamora R, Cifuentes-Araneda F, Gonzalez AA, Amador CA, Pacheco R, Michea L. Myeloid CD11c(+) Antigen-Presenting cells ablation prevents hypertension in response to angiotensin II plus High-Salt diet. Hypertension. 2018;71:709\u201318.","journal-title":"Hypertension"},{"key":"3323_CR215","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.116.07493","volume":"68","author":"AE Norlander","year":"2016","unstructured":"Norlander AE, Saleh MA, Kamat NV, Ko B, Gnecco J, Zhu L, Dale BL, Iwakura Y, Hoover RS, McDonough AA, Madhur MS. Interleukin-17A regulates renal sodium transporters and renal injury in angiotensin II-Induced hypertension. Hypertension. 2016;68:167\u201374.","journal-title":"Hypertension"},{"key":"3323_CR216","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1742-2094-9-212","volume":"9","author":"KL Wu","year":"2012","unstructured":"Wu KL, Chan SH, Chan JY. Neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation. J Neuroinflammation. 2012;9:212.","journal-title":"J Neuroinflammation"},{"key":"3323_CR217","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/ajh\/hpy168","volume":"32","author":"B Rodriguez-Iturbe","year":"2019","unstructured":"Rodriguez-Iturbe B, Johnson RJ. Genetic polymorphisms in hypertension: are we missing the immune connection?? Am J Hypertens. 2019;32:113\u201322.","journal-title":"Am J Hypertens"},{"key":"3323_CR218","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27\u201341.","journal-title":"Immunity"},{"key":"3323_CR219","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41571-020-00459-9","volume":"18","author":"J Hou","year":"2021","unstructured":"Hou J, Karin M, Sun B. Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age? Nat Rev Clin Oncol. 2021;18:261\u201379.","journal-title":"Nat Rev Clin Oncol"},{"key":"3323_CR220","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1096\/fj.04-3213fje","volume":"19","author":"EA Komarova","year":"2005","unstructured":"Komarova EA, Krivokrysenko V, Wang K, Neznanov N, Chernov MV, Komarov PG, Brennan ML, Golovkina TV, Rokhlin OW, Kuprash DV, et al. p53 is a suppressor of inflammatory response in mice. Faseb J. 2005;19:1030\u20132.","journal-title":"Faseb J"},{"key":"3323_CR221","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ccr.2012.11.014","volume":"23","author":"S Schwitalla","year":"2013","unstructured":"Schwitalla S, Ziegler PK, Horst D, Becker V, Kerle I, Begus-Nahrmann Y, Lechel A, Rudolph KL, Langer R, Slotta-Huspenina J, et al. Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. Cancer Cell. 2013;23:93\u2013106.","journal-title":"Cancer Cell"},{"key":"3323_CR222","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nature09673","volume":"470","author":"E Elyada","year":"2011","unstructured":"Elyada E, Pribluda A, Goldstein RE, Morgenstern Y, Brachya G, Cojocaru G, Snir-Alkalay I, Burstain I, Haffner-Krausz R, Jung S, et al. CKI\u03b1 ablation highlights a critical role for p53 in invasiveness control. Nature. 2011;470:409\u201313.","journal-title":"Nature"},{"key":"3323_CR223","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ccr.2013.06.005","volume":"24","author":"A Pribluda","year":"2013","unstructured":"Pribluda A, Elyada E, Wiener Z, Hamza H, Goldstein RE, Biton M, Burstain I, Morgenstern Y, Brachya G, Billauer H, et al. A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell. 2013;24:242\u201356.","journal-title":"Cancer Cell"},{"key":"3323_CR224","first-page":"161","volume":"1","author":"J Hou","year":"2004","unstructured":"Hou J, Tian L, Wei Y. Cancer immunotherapy of targeting angiogenesis. Cell Mol Immunol. 2004;1:161\u20136.","journal-title":"Cell Mol Immunol"},{"key":"3323_CR225","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/eurheartj\/ehu119","volume":"35","author":"N Idris-Khodja","year":"2014","unstructured":"Idris-Khodja N, Mian MO, Paradis P, Schiffrin EL. Dual opposing roles of adaptive immunity in hypertension. Eur Heart J. 2014;35:1238\u201344.","journal-title":"Eur Heart J"},{"key":"3323_CR226","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41581-024-00838-w","volume":"20","author":"BA Nguyen","year":"2024","unstructured":"Nguyen BA, Alexander MR, Harrison DG. Immune mechanisms in the pathophysiology of hypertension. Nat Rev Nephrol. 2024;20:530\u201340.","journal-title":"Nat Rev Nephrol"},{"key":"3323_CR227","first-page":"398","volume":"67","author":"EM Ward","year":"2017","unstructured":"Ward EM, Flowers CR, Gansler T, Omer SB, Bednarczyk RA. The importance of immunization in cancer prevention, treatment, and survivorship. CA Cancer J Clin. 2017;67:398\u2013410.","journal-title":"CA Cancer J Clin"},{"key":"3323_CR228","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.phrs.2017.03.015","volume":"120","author":"JM Abais-Battad","year":"2017","unstructured":"Abais-Battad JM, Dasinger JH, Fehrenbach DJ, Mattson DL. Novel adaptive and innate immunity targets in hypertension. Pharmacol Res. 2017;120:109\u201315.","journal-title":"Pharmacol Res"},{"key":"3323_CR229","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1111\/bph.14427","volume":"176","author":"A Caillon","year":"2019","unstructured":"Caillon A, Paradis P, Schiffrin EL. Role of immune cells in hypertension. Br J Pharmacol. 2019;176:1818\u201328.","journal-title":"Br J Pharmacol"},{"key":"3323_CR230","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/CIRCRESAHA.116.301312","volume":"116","author":"G Tellides","year":"2015","unstructured":"Tellides G, Pober JS. Inflammatory and immune responses in the arterial media. Circ Res. 2015;116:312\u201322.","journal-title":"Circ Res"},{"key":"3323_CR231","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1161\/01.ATV.0000181743.28028.57","volume":"25","author":"C De Ciuceis","year":"2005","unstructured":"De Ciuceis C, Amiri F, Brassard P, Endemann DH, Touyz RM, Schiffrin EL. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler Thromb Vasc Biol. 2005;25:2106\u201313.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3323_CR232","doi-asserted-by":"publisher","first-page":"H1789","DOI":"10.1152\/ajpheart.01118.2006","volume":"292","author":"EA Ko","year":"2007","unstructured":"Ko EA, Amiri F, Pandey NR, Javeshghani D, Leibovitz E, Touyz RM, Schiffrin EL. Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice. Am J Physiol Heart Circ Physiol. 2007;292:H1789\u20131795.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3323_CR233","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1152\/physrev.00031.2016","volume":"97","author":"B Rodriguez-Iturbe","year":"2017","unstructured":"Rodriguez-Iturbe B, Pons H, Johnson RJ. Role of the immune system in hypertension. Physiol Rev. 2017;97:1127\u201364.","journal-title":"Physiol Rev"},{"key":"3323_CR234","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.116.07237","volume":"68","author":"HA Itani","year":"2016","unstructured":"Itani HA, McMaster WG Jr., Saleh MA, Nazarewicz RR, Mikolajczyk TP, Kaszuba AM, Konior A, Prejbisz A, Januszewicz A, Norlander AE, et al. Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans. Hypertension. 2016;68:123\u201332.","journal-title":"Hypertension"},{"key":"3323_CR235","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1161\/CIRCULATIONAHA.119.045102","volume":"141","author":"M Siedlinski","year":"2020","unstructured":"Siedlinski M, Jozefczuk E, Xu X, Teumer A, Evangelou E, Schnabel RB, Welsh P, Maffia P, Erdmann J, Tomaszewski M, et al. White blood cells and blood pressure: A Mendelian randomization study. Circulation. 2020;141:1307\u201317.","journal-title":"Circulation"},{"key":"3323_CR236","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1097\/JTO.0b013e318174e9a7","volume":"3","author":"PA Bradbury","year":"2008","unstructured":"Bradbury PA, Shepherd FA. Immunotherapy for lung cancer. J Thorac Oncol. 2008;3:S164\u2013170.","journal-title":"J Thorac Oncol"},{"key":"3323_CR237","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","volume":"22","author":"A Lahiri","year":"2023","unstructured":"Lahiri A, Maji A, Potdar PD, Singh N, Parikh P, Bisht B, Mukherjee A, Paul MK. Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer. 2023;22:40.","journal-title":"Mol Cancer"},{"key":"3323_CR238","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/ng2030","volume":"39","author":"T Sun","year":"2007","unstructured":"Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, Guo Y, Yang M, Zhang X, Zhang Q, et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet. 2007;39:605\u201313.","journal-title":"Nat Genet"},{"key":"3323_CR239","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12943-024-01976-2","volume":"23","author":"G Polcaro","year":"2024","unstructured":"Polcaro G, Liguori L, Manzo V, Chianese A, Donadio G, Caputo A, Scognamiglio G, Dell\u2019Annunziata F, Langella M, Corbi G, et al. rs822336 binding to C\/EBP\u03b2 and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1\/PD-L1 therapy in advanced NSCLC. Mol Cancer. 2024;23:63.","journal-title":"Mol Cancer"},{"key":"3323_CR240","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/HYPERTENSIONAHA.117.07802","volume":"70","author":"TJ Guzik","year":"2017","unstructured":"Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension. 2017;70:660\u20137.","journal-title":"Hypertension"},{"key":"3323_CR241","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/HYPERTENSIONAHA.115.06163","volume":"66","author":"RA Lopes","year":"2015","unstructured":"Lopes RA, Neves KB, Tostes RC, Montezano AC, Touyz RM. Downregulation of nuclear factor erythroid 2-Related factor and associated antioxidant genes contributes to Redox-Sensitive vascular dysfunction in hypertension. Hypertension. 2015;66:1240\u201350.","journal-title":"Hypertension"},{"key":"3323_CR242","doi-asserted-by":"crossref","unstructured":"Camargo LL, Rios FJ, Montezano AC, Touyz RM. Reactive oxygen species in hypertension. Nat Rev Cardiol 2024.","DOI":"10.1038\/s41569-024-01062-6"},{"issue":"Suppl 2","key":"3323_CR243","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.2337\/dc08-s246","volume":"31","author":"E Grossman","year":"2008","unstructured":"Grossman E. Does increased oxidative stress cause hypertension? Diabetes Care. 2008;31(Suppl 2):S185\u2013189.","journal-title":"Diabetes Care"},{"key":"3323_CR244","first-page":"575","volume":"34","author":"JR Petrie","year":"2018","unstructured":"Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34:575\u201384.","journal-title":"Can J Cardiol"},{"key":"3323_CR245","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2174\/18756506OTg2CNjUuTcVY","volume":"16","author":"LC Pinheiro","year":"2020","unstructured":"Pinheiro LC, Oliveira-Paula GH. Sources and effects of oxidative stress in hypertension. Curr Hypertens Rev. 2020;16:166\u201380.","journal-title":"Curr Hypertens Rev"},{"key":"3323_CR246","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/CIRCRESAHA.121.318063","volume":"128","author":"KK Griendling","year":"2021","unstructured":"Griendling KK, Camargo LL, Rios FJ, Alves-Lopes R, Montezano AC, Touyz RM. Oxidative stress and hypertension. Circ Res. 2021;128:993\u20131020.","journal-title":"Circ Res"},{"key":"3323_CR247","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1080\/13510002.2017.1372072","volume":"22","author":"H Pawluk","year":"2017","unstructured":"Pawluk H, Pawluk R, Robaczewska J, K\u0119dziora-Kornatowska K, K\u0119dziora J. Biomarkers of antioxidant status and lipid peroxidation in elderly patients with hypertension. Redox Rep. 2017;22:542\u20136.","journal-title":"Redox Rep"},{"key":"3323_CR248","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40246-018-0162-6","volume":"12","author":"M Kim","year":"2018","unstructured":"Kim M, Kim M, Yoo HJ, Shon J, Lee JH. Associations between hypertension and the peroxisome proliferator-activated receptor-\u03b4 (PPARD) gene rs7770619 C\u2009>\u2009T polymorphism in a Korean population. Hum Genomics. 2018;12:28.","journal-title":"Hum Genomics"},{"key":"3323_CR249","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.semcancer.2017.10.005","volume":"49","author":"S Ahmad","year":"2018","unstructured":"Ahmad S, Khan MY, Rafi Z, Khan H, Siddiqui Z, Rehman S, Shahab U, Khan MS, Saeed M, Alouffi S, Khan MS. Oxidation, glycation and glycoxidation-The vicious cycle and lung cancer. Semin Cancer Biol. 2018;49:29\u201336.","journal-title":"Semin Cancer Biol"},{"key":"3323_CR250","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2741\/s474","volume":"9","author":"S Ahmad","year":"2017","unstructured":"Ahmad S, Khan H, Shahab U, Rehman S, Rafi Z, Khan MY, Ansari A, Siddiqui Z, Ashraf JM, Abdullah SM, et al. Protein oxidation: an overview of metabolism of sulphur containing amino acid, cysteine. Front Biosci (Schol Ed). 2017;9:71\u201387.","journal-title":"Front Biosci (Schol Ed)"},{"key":"3323_CR251","first-page":"934","volume":"4","author":"Y Xu","year":"2014","unstructured":"Xu Y, Pan Q, Wang C, He C, Su Z, Guo X, Zhang J, Kong M, Ke S, Zhang J, et al. Genetic polymorphisms in oxidative stress-related genes are associated with clinical outcome in patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitors. Am J Cancer Res. 2014;4:934\u201342.","journal-title":"Am J Cancer Res"},{"key":"3323_CR252","doi-asserted-by":"publisher","first-page":"e0119100","DOI":"10.1371\/journal.pone.0119100","volume":"10","author":"SY Eom","year":"2015","unstructured":"Eom SY, Yim DH, Lee CH, Choe KH, An JY, Lee KY, Kim YD, Kim H. Interactions between paraoxonase 1 genetic polymorphisms and smoking and their effects on oxidative stress and lung cancer risk in a Korean population. PLoS ONE. 2015;10:e0119100.","journal-title":"PLoS ONE"},{"key":"3323_CR253","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1161\/HYPERTENSIONAHA.120.13896","volume":"75","author":"S Chakraborty","year":"2020","unstructured":"Chakraborty S, Mandal J, Yang T, Cheng X, Yeo JY, McCarthy CG, Wenceslau CF, Koch LG, Hill JW, Vijay-Kumar M, Joe B. Metabolites and hypertension: insights into hypertension as a metabolic disorder: 2019 Harriet Dustan award. Hypertension. 2020;75:1386\u201396.","journal-title":"Hypertension"},{"key":"3323_CR254","doi-asserted-by":"crossref","unstructured":"Chen M, Li H, Li Y, Luo Y, He Y, Shui X, Lei W. Glycolysis modulation: new therapeutic strategies to improve pulmonary hypertension (Review). Int J Mol Med 2024, 54.","DOI":"10.3892\/ijmm.2024.5439"},{"key":"3323_CR255","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1158\/2159-8290.CD-20-1211","volume":"11","author":"P Dey","year":"2021","unstructured":"Dey P, Kimmelman AC, DePinho RA. Metabolic codependencies in the tumor microenvironment. Cancer Discov. 2021;11:1067\u201381.","journal-title":"Cancer Discov"},{"key":"3323_CR256","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer\u2019s achilles\u2019 heel. Cancer Cell. 2008;13:472\u201382.","journal-title":"Cancer Cell"},{"key":"3323_CR257","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1089\/ars.2020.8042","volume":"34","author":"CM Moshfegh","year":"2021","unstructured":"Moshfegh CM, Case AJ. The Redox-Metabolic couple of T lymphocytes: potential consequences for hypertension. Antioxid Redox Signal. 2021;34:915\u201335.","journal-title":"Antioxid Redox Signal"},{"key":"3323_CR258","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11906-007-0056-9","volume":"9","author":"J Redon","year":"2007","unstructured":"Redon J, C\u00edfkov\u00e1 R. The metabolic syndrome in hypertension: diagnostic and therapeutic implications. Curr Hypertens Rep. 2007;9:305\u201313.","journal-title":"Curr Hypertens Rep"},{"key":"3323_CR259","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/cs0910539","volume":"91","author":"CJ Dickinson","year":"1996","unstructured":"Dickinson CJ. Cerebral oxidative metabolism in hypertension. Clin Sci (Lond). 1996;91:539\u201350.","journal-title":"Clin Sci (Lond)"},{"key":"3323_CR260","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.autneu.2018.01.002","volume":"210","author":"D Haspula","year":"2018","unstructured":"Haspula D, Clark MA. Neuroinflammation and sympathetic overactivity: mechanisms and implications in hypertension. Auton Neurosci. 2018;210:10\u20137.","journal-title":"Auton Neurosci"},{"key":"3323_CR261","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11883-016-0632-z","volume":"18","author":"J Hurtubise","year":"2016","unstructured":"Hurtubise J, McLellan K, Durr K, Onasanya O, Nwabuko D, Ndisang JF. The different facets of dyslipidemia and hypertension in atherosclerosis. Curr Atheroscler Rep. 2016;18:82.","journal-title":"Curr Atheroscler Rep"},{"key":"3323_CR262","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12944-021-01435-7","volume":"20","author":"R Akhigbe","year":"2021","unstructured":"Akhigbe R, Ajayi A. The impact of reactive oxygen species in the development of cardiometabolic disorders: a review. Lipids Health Dis. 2021;20:23.","journal-title":"Lipids Health Dis"},{"key":"3323_CR263","doi-asserted-by":"crossref","unstructured":"Ansari RA, Husain K, Rizvi SA. Role of transcription factors in steatohepatitis and hypertension after ethanol: the epicenter of metabolism. Biomolecules 2016, 6.","DOI":"10.3390\/biom6030029"},{"key":"3323_CR264","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1089\/ars.2020.8108","volume":"34","author":"H Wang","year":"2021","unstructured":"Wang H, Li Q, Zhu Y, Zhang X. Omega-3 polyunsaturated fatty acids: versatile roles in blood pressure regulation. Antioxid Redox Signal. 2021;34:800\u201310.","journal-title":"Antioxid Redox Signal"},{"key":"3323_CR265","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1467-789X.2011.00914.x","volume":"13","author":"JA Dorresteijn","year":"2012","unstructured":"Dorresteijn JA, Visseren FL, Spiering W. Mechanisms linking obesity to hypertension. Obes Rev. 2012;13:17\u201326.","journal-title":"Obes Rev"},{"key":"3323_CR266","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","volume":"187","author":"SM Fendt","year":"2024","unstructured":"Fendt SM. 100 years of the Warburg effect: A cancer metabolism endeavor. Cell. 2024;187:3824\u20138.","journal-title":"Cell"},{"key":"3323_CR267","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","volume":"52","author":"EL Lieu","year":"2020","unstructured":"Lieu EL, Nguyen T, Rhyne S, Kim J. Amino acids in cancer. Exp Mol Med. 2020;52:15\u201330.","journal-title":"Exp Mol Med"},{"key":"3323_CR268","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.semcancer.2017.01.005","volume":"43","author":"L Schwartz","year":"2017","unstructured":"Schwartz L, Seyfried T, Alfarouk KO, Da Veiga Moreira J, Fais S. Out of Warburg effect: an effective cancer treatment targeting the tumor specific metabolism and dysregulated pH. Semin Cancer Biol. 2017;43:134\u20138.","journal-title":"Semin Cancer Biol"},{"key":"3323_CR269","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10555-022-10059-x","volume":"41","author":"A Mukherjee","year":"2022","unstructured":"Mukherjee A, Bilecz AJ, Lengyel E. The adipocyte microenvironment and cancer. Cancer Metastasis Rev. 2022;41:575\u201387.","journal-title":"Cancer Metastasis Rev"},{"key":"3323_CR270","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canlet.2019.08.014","volume":"470","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhu B, Zeng Y, Shen H, Zhang J, Wang X. Clinical lipidomics in Understanding of lung cancer: opportunity and challenge. Cancer Lett. 2020;470:75\u201383.","journal-title":"Cancer Lett"},{"key":"3323_CR271","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fonc.2020.00276","volume":"10","author":"JF Fahrmann","year":"2020","unstructured":"Fahrmann JF, Vykoukal JV, Ostrin EJ. Amino acid oncometabolism and Immunomodulation of the tumor microenvironment in lung cancer. Front Oncol. 2020;10:276.","journal-title":"Front Oncol"},{"key":"3323_CR272","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/annonc\/mdq212","volume":"21","author":"Z Sun","year":"2010","unstructured":"Sun Z, Chen J, Aakre J, Marks RS, Garces YY, Jiang R, Idowu O, Cunningham JM, Liu Y, Pankratz VS, Yang P. Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients. Ann Oncol. 2010;21:2011\u20136.","journal-title":"Ann Oncol"},{"key":"3323_CR273","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","volume":"73","author":"T Gutschner","year":"2013","unstructured":"Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73:1180\u20139.","journal-title":"Cancer Res"},{"key":"3323_CR274","doi-asserted-by":"publisher","first-page":"155333","DOI":"10.1016\/j.phymed.2023.155333","volume":"128","author":"C Fang","year":"2024","unstructured":"Fang C, Wu W, Ni Z, Liu Y, Luo J, Zhou Y, Gong C, Hu D, Yao C, Chen X, et al. Ailanthone inhibits non-small cell lung cancer growth and metastasis through targeting UPF1\/GAS5\/ULK1 signaling pathway. Phytomedicine. 2024;128:155333.","journal-title":"Phytomedicine"},{"key":"3323_CR275","doi-asserted-by":"crossref","unstructured":"Nguyen LNT, Pyburn JS, Nguyen NL, Schank MB, Zhao J, Wang L, Leshaodo TO, El Gazzar M, Moorman JP, Yao ZQ. Epigenetic regulation by LncRNA GAS5\/miRNA\/mRNA network in human diseases. Int J Mol Sci 2025, 26.","DOI":"10.3390\/ijms26031377"},{"key":"3323_CR276","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1093\/nar\/gkw093","volume":"44","author":"J Wang","year":"2016","unstructured":"Wang J, Ma R, Ma W, Chen J, Yang J, Xi Y, Cui Q. LncDisease: a sequence based bioinformatics tool for predicting lncRNA-disease associations. Nucleic Acids Res. 2016;44:e90.","journal-title":"Nucleic Acids Res"},{"key":"3323_CR277","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/cvr\/cvac058","volume":"119","author":"ST Keating","year":"2023","unstructured":"Keating ST, El-Osta A. Metaboloepigenetics in cancer, immunity, and cardiovascular disease. Cardiovasc Res. 2023;119:357\u201370.","journal-title":"Cardiovasc Res"},{"key":"3323_CR278","doi-asserted-by":"publisher","first-page":"123563","DOI":"10.1016\/j.envpol.2024.123563","volume":"345","author":"G Yu","year":"2024","unstructured":"Yu G, Wu L, Su Q, Ji X, Zhou J, Wu S, Tang Y, Li H. Neurotoxic effects of heavy metal pollutants in the environment: focusing on epigenetic mechanisms. Environ Pollut. 2024;345:123563.","journal-title":"Environ Pollut"},{"key":"3323_CR279","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13148-025-01856-6","volume":"17","author":"H Zhang","year":"2025","unstructured":"Zhang H, Pang Y, Yi L, Wang X, Wei P, Wang H, Lin S. Epigenetic regulators combined with tumour immunotherapy: current status and perspectives. Clin Epigenetics. 2025;17:51.","journal-title":"Clin Epigenetics"},{"key":"3323_CR280","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2014.08.002","volume":"18","author":"D Corella","year":"2014","unstructured":"Corella D, Ordovas JM. Aging and cardiovascular diseases: the role of gene-diet interactions. Ageing Res Rev. 2014;18:53\u201373.","journal-title":"Ageing Res Rev"},{"key":"3323_CR281","doi-asserted-by":"publisher","first-page":"e000138","DOI":"10.1161\/HCQ.0000000000000138","volume":"18","author":"SF Suglia","year":"2025","unstructured":"Suglia SF, Hidalgo B, Baccarelli AA, Cardenas A, Damrauer S, Johnson A, Key K, Liang M, Magnani JW, Pate B, et al. Improving cardiovascular health through the consideration of social factors in genetics and genomics research: A scientific statement from the American heart association. Circ Cardiovasc Qual Outcomes. 2025;18:e000138.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"3323_CR282","doi-asserted-by":"publisher","first-page":"102174","DOI":"10.1016\/j.cpcardiol.2023.102174","volume":"49","author":"T Abdul-Rahman","year":"2024","unstructured":"Abdul-Rahman T, Roy P, Bliss ZSB, Mohammad A, Corriero AC, Patel NT, Wireko AA, Shaikh R, Faith OE, Arevalo-Rios ECE, et al. The impact of air quality on cardiovascular health: A state of the Art review. Curr Probl Cardiol. 2024;49:102174.","journal-title":"Curr Probl Cardiol"},{"key":"3323_CR283","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1289\/ehp.1306981","volume":"122","author":"W Babisch","year":"2014","unstructured":"Babisch W, Wolf K, Petz M, Heinrich J, Cyrys J, Peters A. Associations between traffic noise, particulate air pollution, hypertension, and isolated systolic hypertension in adults: the KORA study. Environ Health Perspect. 2014;122:492\u20138.","journal-title":"Environ Health Perspect"},{"key":"3323_CR284","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrc3572","volume":"13","author":"L Fajersztajn","year":"2013","unstructured":"Fajersztajn L, Veras M, Barrozo LV, Saldiva P. Air pollution: a potentially modifiable risk factor for lung cancer. Nat Rev Cancer. 2013;13:674\u20138.","journal-title":"Nat Rev Cancer"},{"key":"3323_CR285","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.jacc.2012.08.973","volume":"60","author":"RM Krishnan","year":"2012","unstructured":"Krishnan RM, Adar SD, Szpiro AA, Jorgensen NW, Van Hee VC, Barr RG, O\u2019Neill MS, Herrington DM, Polak JF, Kaufman JD. Vascular responses to long- and short-term exposure to fine particulate matter: MESA air (Multi-Ethnic study of atherosclerosis and air Pollution). J Am Coll Cardiol. 2012;60:2158\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"3323_CR286","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1093\/eurheartj\/ehy481","volume":"39","author":"T M\u00fcnzel","year":"2018","unstructured":"M\u00fcnzel T, Gori T, Al-Kindi S, Deanfield J, Lelieveld J, Daiber A, Rajagopalan S. Effects of gaseous and solid constituents of air pollution on endothelial function. Eur Heart J. 2018;39:3543\u201350.","journal-title":"Eur Heart J"},{"key":"3323_CR287","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1097\/JTO.0b013e3181f387e4","volume":"5","author":"DS O\u2019Callaghan","year":"2010","unstructured":"O\u2019Callaghan DS, O\u2019Donnell D, O\u2019Connell F, O\u2019Byrne KJ. The role of inflammation in the pathogenesis of non-small cell lung cancer. J Thorac Oncol. 2010;5:2024\u201336.","journal-title":"J Thorac Oncol"},{"key":"3323_CR288","doi-asserted-by":"crossref","unstructured":"Swinnen K, Bijnens E, Casas L, Nawrot TS, Delcroix M, Quarck R, Belge C. Health effects of exposure to residential air pollution in patients with pulmonary arterial hypertension: a cohort study in Belgium. Eur Respir J 2022, 60.","DOI":"10.1183\/13993003.02335-2021"},{"key":"3323_CR289","doi-asserted-by":"publisher","first-page":"128937","DOI":"10.1016\/j.jhazmat.2022.128937","volume":"434","author":"Y Xue","year":"2022","unstructured":"Xue Y, Wang L, Zhang Y, Zhao Y, Liu Y. Air pollution: A culprit of lung cancer. J Hazard Mater. 2022;434:128937.","journal-title":"J Hazard Mater"},{"key":"3323_CR290","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.scib.2024.03.028","volume":"69","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Chen S, Wei J, Jiang J, Lin X, Wang Y, Hao C, Wu W, Yuan Z, Sun J, et al. Long-term PM(1) exposure and hypertension hospitalization: A causal inference study on a large community-based cohort in South China. Sci Bull (Beijing). 2024;69:1313\u201322.","journal-title":"Sci Bull (Beijing)"},{"key":"3323_CR291","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nrc1190","volume":"3","author":"SS Hecht","year":"2003","unstructured":"Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003;3:733\u201344.","journal-title":"Nat Rev Cancer"},{"key":"3323_CR292","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41568-021-00423-4","volume":"22","author":"SS Hecht","year":"2022","unstructured":"Hecht SS, Hatsukami DK. Smokeless tobacco and cigarette smoking: chemical mechanisms and cancer prevention. Nat Rev Cancer. 2022;22:143\u201355.","journal-title":"Nat Rev Cancer"},{"key":"3323_CR293","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3109\/08037051.2010.484150","volume":"19","author":"D Hering","year":"2010","unstructured":"Hering D, Kucharska W, Kara T, Somers VK, Narkiewicz K. Smoking is associated with chronic sympathetic activation in hypertension. Blood Press. 2010;19:152\u20135.","journal-title":"Blood Press"},{"issue":"Suppl 1","key":"3323_CR294","doi-asserted-by":"publisher","first-page":"I52","DOI":"10.1007\/s003950070010","volume":"95","author":"U Keil","year":"2000","unstructured":"Keil U. Coronary artery disease: the role of lipids, hypertension and smoking. Basic Res Cardiol. 2000;95(Suppl 1):I52\u201358.","journal-title":"Basic Res Cardiol"},{"key":"3323_CR295","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11906-020-01085-7","volume":"22","author":"J Lynch","year":"2020","unstructured":"Lynch J, Jin L, Richardson A, Conklin DJ. Tobacco smoke and endothelial dysfunction: role of aldehydes?? Curr Hypertens Rep. 2020;22:73.","journal-title":"Curr Hypertens Rep"},{"issue":"Suppl 2","key":"3323_CR296","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003495-199856002-00001","volume":"56","author":"H Pardell","year":"1998","unstructured":"Pardell H, Armario P, Hern\u00e1ndez R. [Pathogenesis and epidemiology of arterial hypertension]. Drugs. 1998;56(Suppl 2):1\u201310.","journal-title":"Drugs"},{"key":"3323_CR297","first-page":"1","volume":"11","author":"YY Cheng","year":"2020","unstructured":"Cheng YY, Rath EM, Linton A, Yuen ML, Takahashi K, Lee K. The current Understanding of Asbestos-Induced epigenetic changes associated with lung cancer. Lung Cancer (Auckl). 2020;11:1\u201311.","journal-title":"Lung Cancer (Auckl)"},{"key":"3323_CR298","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/10937404.2018.1432025","volume":"21","author":"A da Cunha Martins Jr","year":"2018","unstructured":"da Cunha Martins A Jr., Carneiro MFH, Grotto D, Adeyemi JA, Barbosa F Jr. Arsenic, cadmium, and mercury-induced hypertension: mechanisms and epidemiological findings. J Toxicol Environ Health B Crit Rev. 2018;21:61\u201382.","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"3323_CR299","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.envres.2017.08.049","volume":"159","author":"P Fern\u00e1ndez-Navarro","year":"2017","unstructured":"Fern\u00e1ndez-Navarro P, Garc\u00eda-P\u00e9rez J, Ramis R, Boldo E, L\u00f3pez-Abente G. Industrial pollution and cancer in spain: an important public health issue. Environ Res. 2017;159:555\u201363.","journal-title":"Environ Res"},{"key":"3323_CR300","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.123.323617","volume":"134","author":"Z Pan","year":"2024","unstructured":"Pan Z, Gong T, Liang P. Heavy metal exposure and cardiovascular disease. Circ Res. 2024;134:1160\u201378.","journal-title":"Circ Res"},{"key":"3323_CR301","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.mrrev.2019.04.004","volume":"781","author":"P Paul","year":"2019","unstructured":"Paul P, Malakar AK, Chakraborty S. The significance of gene mutations across eight major cancer types. Mutat Res Rev Mutat Res. 2019;781:88\u201399.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"3323_CR302","doi-asserted-by":"publisher","first-page":"115716","DOI":"10.1016\/j.jenvman.2022.115716","volume":"319","author":"LP Thives","year":"2022","unstructured":"Thives LP, Ghisi E, Thives J\u00fanior JJ, Vieira AS. Is asbestos still a problem in the world? A current review. J Environ Manage. 2022;319:115716.","journal-title":"J Environ Manage"},{"key":"3323_CR303","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.scitotenv.2017.11.343","volume":"622\u2013623","author":"W Wu","year":"2018","unstructured":"Wu W, Jiang S, Zhao Q, Zhang K, Wei X, Zhou T, Liu D, Zhou H, Zhong R, Zeng Q, et al. Associations of environmental exposure to metals with the risk of hypertension in China. Sci Total Environ. 2018;622\u2013623:184\u201391.","journal-title":"Sci Total Environ"},{"key":"3323_CR304","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/cvr\/cvz091","volume":"115","author":"HA Jama","year":"2019","unstructured":"Jama HA, Beale A, Shihata WA, Marques FZ. The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immunometabolism? Cardiovasc Res. 2019;115:1435\u201347.","journal-title":"Cardiovasc Res"},{"key":"3323_CR305","doi-asserted-by":"crossref","unstructured":"Kobets T, Smith BPC, Williams GM. Food-Borne Chemical Carcinogens and the Evidence for Human Cancer Risk. Foods 2022, 11.","DOI":"10.3390\/foods11182828"},{"key":"3323_CR306","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.trecan.2019.09.007","volume":"5","author":"B Peck","year":"2019","unstructured":"Peck B, Schulze A. Lipid metabolism at the nexus of diet and tumor microenvironment. Trends Cancer. 2019;5:693\u2013703.","journal-title":"Trends Cancer"},{"key":"3323_CR307","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.kint.2017.02.034","volume":"91","author":"J Titze","year":"2017","unstructured":"Titze J, Luft FC. Speculations on salt and the genesis of arterial hypertension. Kidney Int. 2017;91:1324\u201335.","journal-title":"Kidney Int"},{"key":"3323_CR308","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41568-019-0231-8","volume":"20","author":"M Vishwakarma","year":"2020","unstructured":"Vishwakarma M, Piddini E. Outcompeting cancer. Nat Rev Cancer. 2020;20:187\u201398.","journal-title":"Nat Rev Cancer"},{"key":"3323_CR309","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s12011-022-03153-2","volume":"201","author":"S Balarastaghi","year":"2023","unstructured":"Balarastaghi S, Rezaee R, Hayes AW, Yarmohammadi F, Karimi G. Mechanisms of arsenic Exposure-Induced hypertension and atherosclerosis: an updated overview. Biol Trace Elem Res. 2023;201:98\u2013113.","journal-title":"Biol Trace Elem Res"},{"key":"3323_CR310","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.semcancer.2019.04.003","volume":"57","author":"L Li","year":"2019","unstructured":"Li L, Bi Z, Wadgaonkar P, Lu Y, Zhang Q, Fu Y, Thakur C, Wang L, Chen F. Metabolic and epigenetic reprogramming in the arsenic-induced cancer stem cells. Semin Cancer Biol. 2019;57:10\u20138.","journal-title":"Semin Cancer Biol"},{"key":"3323_CR311","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.envint.2017.12.017","volume":"112","author":"BC Minatel","year":"2018","unstructured":"Minatel BC, Sage AP, Anderson C, Hubaux R, Marshall EA, Lam WL, Martinez VD. Environmental arsenic exposure: from genetic susceptibility to pathogenesis. Environ Int. 2018;112:183\u201397.","journal-title":"Environ Int"},{"key":"3323_CR312","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.semcancer.2021.03.019","volume":"76","author":"WN Saintilnord","year":"2021","unstructured":"Saintilnord WN, Fondufe-Mittendorf Y. Arsenic-induced epigenetic changes in cancer development. Semin Cancer Biol. 2021;76:195\u2013205.","journal-title":"Semin Cancer Biol"},{"key":"3323_CR313","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semcancer.2021.05.009","volume":"76","author":"X Zhou","year":"2021","unstructured":"Zhou X, Speer RM, Volk L, Hudson LG, Liu KJ. Arsenic co-carcinogenesis: Inhibition of DNA repair and interaction with zinc finger proteins. Semin Cancer Biol. 2021;76:86\u201398.","journal-title":"Semin Cancer Biol"},{"key":"3323_CR314","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s13280-021-01589-9","volume":"51","author":"K Blackburn","year":"2022","unstructured":"Blackburn K, Green D. The potential effects of microplastics on human health: what is known and what is unknown. Ambio. 2022;51:518\u201330.","journal-title":"Ambio"},{"key":"3323_CR315","doi-asserted-by":"crossref","unstructured":"Campanale C, Massarelli C, Savino I, Locaputo V, Uricchio VF. A detailed review study on potential effects of microplastics and additives of concern on human health. Int J Environ Res Public Health 2020, 17.","DOI":"10.3390\/ijerph17041212"},{"key":"3323_CR316","doi-asserted-by":"crossref","unstructured":"Kadac-Czapska K, O\u015bko J, Knez E, Grembecka M. Microplastics and oxidative Stress-Current problems and prospects. Antioxid (Basel) 2024, 13.","DOI":"10.3390\/antiox13050579"},{"key":"3323_CR317","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12989-022-00500-y","volume":"19","author":"EH Kim","year":"2022","unstructured":"Kim EH, Choi S, Kim D, Park HJ, Bian Y, Choi SH, Chung HY, Bae ON. Amine-modified nanoplastics promote the procoagulant activation of isolated human red blood cells and thrombus formation in rats. Part Fibre Toxicol. 2022;19:60.","journal-title":"Part Fibre Toxicol"},{"key":"3323_CR318","doi-asserted-by":"publisher","first-page":"112356","DOI":"10.1016\/j.fct.2021.112356","volume":"154","author":"HS Lee","year":"2021","unstructured":"Lee HS, Amarakoon D, Wei CI, Choi KY, Smolensky D, Lee SH. Adverse effect of polystyrene microplastics (PS-MPs) on tube formation and viability of human umbilical vein endothelial cells. Food Chem Toxicol. 2021;154:112356.","journal-title":"Food Chem Toxicol"},{"key":"3323_CR319","doi-asserted-by":"publisher","first-page":"126770","DOI":"10.1016\/j.jhazmat.2021.126770","volume":"421","author":"YY Lu","year":"2022","unstructured":"Lu YY, Li H, Ren H, Zhang X, Huang F, Zhang D, Huang Q, Zhang X. Size-dependent effects of polystyrene nanoplastics on autophagy response in human umbilical vein endothelial cells. J Hazard Mater. 2022;421:126770.","journal-title":"J Hazard Mater"},{"key":"3323_CR320","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1056\/NEJMoa2309822","volume":"390","author":"R Marfella","year":"2024","unstructured":"Marfella R, Prattichizzo F, Sardu C, Fulgenzi G, Graciotti L, Spadoni T, D\u2019Onofrio N, Scisciola L, La Grotta R, Frig\u00e9 C, et al. Microplastics and nanoplastics in atheromas and cardiovascular events. N Engl J Med. 2024;390:900\u201310.","journal-title":"N Engl J Med"},{"key":"3323_CR321","doi-asserted-by":"crossref","unstructured":"P\u0142uciennik K, Sici\u0144ska P, Misztal W, Bukowska B. Important factors affecting induction of cell death, oxidative stress and DNA damage by Nano- and microplastic particles in vitro. Cells 2024, 13.","DOI":"10.3390\/cells13090768"},{"key":"3323_CR322","doi-asserted-by":"publisher","first-page":"e0260181","DOI":"10.1371\/journal.pone.0260181","volume":"16","author":"AK Vlacil","year":"2021","unstructured":"Vlacil AK, B\u00e4nfer S, Jacob R, Trippel N, Kuzu I, Schieffer B, Grote K. Polystyrene microplastic particles induce endothelial activation. PLoS ONE. 2021;16:e0260181.","journal-title":"PLoS ONE"},{"key":"3323_CR323","doi-asserted-by":"crossref","unstructured":"Wade MJ, Bucci K, Rochman CM, Meek MH. Microplastic exposure is associated with epigenomic effects in the model organism pimephales Promelas (fathead minnow). J Hered 2024.","DOI":"10.1093\/jhered\/esae027"},{"key":"3323_CR324","doi-asserted-by":"publisher","first-page":"135942","DOI":"10.1016\/j.chemosphere.2022.135942","volume":"307","author":"L Wang","year":"2022","unstructured":"Wang L, Xu M, Chen J, Zhang X, Wang Q, Wang Y, Cui J, Zhang S. Distinct adverse outcomes and lipid profiles of erythrocytes upon single and combined exposure to cadmium and microplastics. Chemosphere. 2022;307:135942.","journal-title":"Chemosphere"},{"key":"3323_CR325","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1039\/D2EM00301E","volume":"25","author":"L Xuan","year":"2023","unstructured":"Xuan L, Xiao L, Huang R. The geno-toxicological impacts of microplastic (MP) exposure on health: mechanistic pathways and research trends from a Chinese perspective. Environ Sci Process Impacts. 2023;25:26\u201336.","journal-title":"Environ Sci Process Impacts"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03323-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03323-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03323-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T03:30:07Z","timestamp":1757388607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03323-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":325,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3323"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03323-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1548"}}